rfhg_190575.1

Basic information about the TSS

---

TSS ID: rfhg_190575.1 Species: human Chr: chr17		Start: 17820313 End: 17820349 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000577897.2:-161 GeneID: 6720 HGNC/MGI_ID: HGNC:11289 UniProt_ID: J3QLB6 Nearer transcript ids and distances: ENST00000662439.1:362 AK128320:362 view more...

Gene_name: sterol regulatory element binding transcription factor 1 Gene_symbol: SREBF1 Gene_synonyms: SREBP-1c SREBP1 SREBP1a bHLHd1 Gene_source: HGNC:11289

TATA-Box annotation

---

Distance to TSS:	3299
Nearest PromoterID:	NM_001321096
Entrez ID:	6720
Nearest Unigene:	Hs.592123
Nearest Refseq:	NM_004176
Nearest Ensembl:	ENSG00000072310
Gene Name:	sterol regulatory element binding transcription factor 1
Gene Alias:	SREBP1|bHLHd1
Gene Type:	protein-coding
CpG%:	0.083333
GC%:	0.810811
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SREBF1 p2@SREBF1 p3@SREBF1 p4@SREBF1 p5@SREBF1 p6@SREBF1 p7@SREBF1 p8@SREBF1 p9@SREBF1 p10@SREBF1
Sample		p1@SREBF1	p2@SREBF1	p3@SREBF1	p4@SREBF1	p5@SREBF1	p6@SREBF1	p7@SREBF1	p8@SREBF1	p9@SREBF1	p10@SREBF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.91	0.58	1.95	0.58	0.97	0.19	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.50	0.61	3.84	0.40	0.40	0.00	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.87	1.16	2.31	0.00	0.00	0.19	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.44	0.42	1.25	0.42	0.21	0.00	0.21	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.02	0.45	2.25	1.35	0.45	0.00	0.22	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	12.02	0.78	1.74	0.39	0.19	0.00	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.61	0.87	2.40	1.53	0.87	0.00	0.22	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	13.81	0.24	2.18	0.97	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.96	1.07	2.14	0.43	0.21	0.00	0.21	0.43	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	29.56	2.32	4.64	3.48	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.10	0.00	4.04	3.23	1.21	0.00	0.81	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.15	0.81	5.29	1.22	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.02	0.64	5.00	0.32	0.32	0.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.23	0.75	3.16	0.45	0.60	0.00	0.15	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.37	0.88	6.15	0.66	0.66	0.00	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.59	0.25	5.53	0.75	0.25	0.00	0.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.54	0.44	4.59	0.44	0.00	0.00	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	0.84	5.91	0.84	0.42	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.26	0.00	9.06	0.53	0.53	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.01	0.90	4.36	1.50	0.15	0.00	0.00	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.97	0.80	4.01	1.07	0.53	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.16	0.35	3.63	0.86	0.52	0.17	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.25	0.52	4.91	0.52	0.13	0.00	0.52	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.02	0.24	3.40	0.24	0.00	0.00	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.64	0.26	6.19	0.77	0.52	0.26	0.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.79	0.00	7.28	0.63	0.00	0.00	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.84	1.10	4.95	0.00	0.00	0.00	0.00	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.18	0.71	4.72	1.65	0.47	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.48	0.65	5.01	0.81	0.00	0.00	0.48	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.63	0.18	4.71	1.63	0.18	0.00	0.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.63	0.21	5.86	0.21	0.21	0.21	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.52	0.00	4.88	0.78	0.00	0.00	0.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.95	0.42	6.75	0.42	0.63	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.83	0.49	5.11	0.82	0.49	0.00	0.49	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.37	0.56	5.05	0.93	0.00	0.00	0.19	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.20	0.19	2.87	1.92	0.00	0.00	0.96	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.62	0.82	2.66	0.82	0.41	0.00	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.31	0.20	3.83	0.81	0.60	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	17.56	0.54	4.05	0.27	0.00	0.00	0.00	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.00	0.00	2.40	1.20	0.72	0.00	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.65	0.47	2.12	0.24	0.00	0.00	0.00	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	12.88	0.15	3.37	0.29	0.15	0.00	0.15	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.24	0.00	1.90	0.63	0.42	0.00	0.00	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.59	0.35	3.50	1.57	0.17	0.00	0.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.25	0.00	2.61	1.00	0.60	0.00	0.40	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.49	0.23	3.49	0.93	0.00	0.00	0.23	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.04	0.00	1.92	0.96	0.00	0.24	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.22	0.00	2.09	0.00	0.00	0.00	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.38	0.24	3.35	0.24	0.00	0.00	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.73	0.61	3.44	1.01	0.20	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.30	0.20	5.33	0.61	0.20	0.00	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.46	0.00	3.11	0.67	0.44	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	13.99	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.87	0.00	3.19	0.71	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.60	0.00	3.65	0.33	0.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2.52	0.00	2.52	3.36	0.00	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.35	0.00	2.76	1.38	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	15.88	0.00	6.81	0.32	0.32	0.00	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.77	0.00	4.50	0.32	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.92	0.00	8.17	0.31	0.31	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	0.00	5.64	0.71	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	0.00	5.05	1.12	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	10.35	0.00	5.57	0.80	0.00	0.00	0.80	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	0.00	5.44	2.38	1.02	0.00	0.34	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.55	0.32	5.85	0.65	0.65	0.00	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.91	0.00	4.26	0.35	0.35	0.71	1.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	32.33	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	0.00	0.00	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.84	0.98	2.44	2.93	0.49	0.49	0.00	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	22.31	1.49	5.95	0.50	0.00	0.50	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	1.41	4.22	0.00	1.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.19	1.99	2.65	1.66	0.33	0.00	0.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.68	1.55	4.95	0.93	0.31	0.00	0.62	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.07	3.06	1.83	1.22	0.31	0.00	0.31	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	8.24	0.48	1.11	0.32	0.32	0.00	0.16	0.63	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	22.14	62.25	3.05	10.27	7.06	6.90	3.05	0.16	0.00	0.96
Adipocyte - omental, donor1	11473-119C6	13.10	5.09	3.05	1.27	0.89	0.25	0.25	0.64	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	3.74	2.24	2.99	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	8.04	9.71	1.67	1.34	2.01	1.00	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	9.57	0.64	3.83	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	30.79	2.20	2.20	0.00	0.00	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	18.52	3.61	2.71	0.00	0.00	0.45	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.42	115.04	2.43	5.04	2.95	3.13	1.22	0.35	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	114.80	130.45	4.50	5.48	3.32	2.15	2.93	0.78	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	75.67	18.53	4.89	1.80	1.03	0.51	0.77	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	76.66	61.89	6.41	5.58	2.23	1.12	0.84	0.84	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	93.46	124.03	5.88	9.40	2.35	3.53	2.35	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	79.95	268.32	2.65	11.90	6.35	5.47	3.30	0.72	0.08	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	80.37	85.85	2.58	6.13	1.94	2.26	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	38.39	65.05	0.53	5.87	7.46	4.27	3.73	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	45.63	101.83	3.90	8.35	2.78	3.34	3.34	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	44.50	274.07	1.66	16.22	2.50	10.40	4.57	0.42	0.00	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	61.79	102.73	3.52	7.79	1.76	3.77	2.51	1.00	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	28.14	110.94	1.96	12.76	2.95	3.60	4.91	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	42.32	175.07	1.83	5.78	3.96	4.87	1.52	0.30	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	28.51	1.55	11.71	0.88	0.22	0.00	0.00	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	71.72	2.51	14.70	2.87	1.79	0.36	1.79	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	0.00	7.19	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.23	7.74	8.82	0.00	0.72	0.00	0.18	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	8.37	5.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	29.79	6.99	4.73	0.82	0.41	0.82	0.41	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	25.40	13.39	5.26	1.49	0.69	0.46	0.11	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	16.65	3.18	4.41	2.94	0.49	0.24	0.24	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.93	3.59	3.15	0.00	0.45	0.00	0.00	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.33	0.43	2.60	2.17	0.43	0.00	0.43	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.55	1.20	1.79	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	0.00	5.06	2.53	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	0.00	0.66	0.66	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.42	0.32	2.60	0.97	0.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	0.49	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	0.00	1.19	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.79	0.00	5.65	0.38	0.75	0.38	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	1.45	2.90	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	1.25	3.76	0.00	1.25	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.23	0.82	1.48	0.49	0.16	0.00	0.00	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	2.73	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.50	0.45	0.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	0.00	3.21	0.00	0.00	0.00	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	12.28	0.57	2.83	0.76	0.38	0.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.09	1.34	2.41	0.00	0.27	0.00	0.00	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	2.93	1.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.60	0.83	2.82	0.33	0.00	0.00	0.17	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	0.00	0.00	1.20	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.24	0.34	3.95	0.34	0.17	0.17	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	1.46	0.97	1.94	0.49	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.38	0.38	2.28	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	2.42	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.98	1.14	5.13	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	0.43	2.35	0.21	0.00	0.21	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.10	0.52	0.77	0.52	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	1.41	2.35	0.47	0.00	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	17.69	0.00	2.25	0.96	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	0.71	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	0.58	0.58	2.34	1.17	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.65	0.60	3.01	0.30	0.30	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	14.24	0.51	3.05	1.53	0.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.55	0.25	3.82	1.02	0.00	0.00	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	0.00	1.91	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.95	2.16	2.59	0.43	0.43	0.00	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.85	0.42	2.33	0.21	0.00	0.00	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.57	1.16	0.58	0.29	0.29	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	0.94	1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.19	0.51	1.19	0.17	0.34	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	0.00	2.11	2.11	2.11	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.51	0.64	1.72	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	0.60	1.80	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	0.00	0.73	0.00	0.00	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.20	0.46	0.69	1.38	0.23	0.00	0.00	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.10	0.25	0.25	0.25	0.00	0.00	0.25	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.73	0.41	2.48	0.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.93	0.00	1.22	0.31	0.31	0.00	0.00	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.64	0.67	2.88	0.00	0.00	0.00	0.44	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	1.53	1.53	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	10.52	0.00	2.77	0.00	0.00	0.00	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.18	0.53	2.91	0.53	0.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.63	0.00	1.09	0.00	0.36	0.00	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	29.72	16.70	10.32	1.35	0.74	0.98	0.25	0.12	0.49	0.25
Astrocyte - cerebellum, donor2	11580-120F5	47.41	16.77	9.93	2.05	0.34	0.51	0.68	0.00	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	17.20	14.68	5.87	0.84	0.21	0.42	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	9.76	20.57	3.83	0.70	0.35	1.74	0.35	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	13.10	29.77	3.07	1.13	1.94	0.97	0.16	0.00	0.00	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	19.54	27.00	4.03	2.24	1.49	1.04	0.30	0.00	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	19.73	4.59	7.57	0.92	1.15	0.00	0.34	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	22.55	5.39	7.39	0.88	1.13	0.25	0.38	0.00	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	19.80	6.83	7.97	1.02	0.57	0.11	0.34	0.00	0.00	0.00
Basophils, donor1	12241-129G9	11.77	0.78	1.83	0.26	0.00	0.00	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	16.96	0.00	2.16	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	24.99	0.59	2.35	0.15	0.15	0.15	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	25.01	17.68	5.61	0.86	1.08	1.08	0.43	0.22	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	34.75	27.43	10.52	4.11	0.46	1.83	0.91	0.00	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	28.69	0.00	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	36.40	11.30	9.41	2.51	0.00	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	33.27	7.28	8.11	1.87	0.21	0.62	1.04	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	53.89	5.30	5.30	3.22	1.84	0.46	0.23	0.46	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	18.53	25.73	4.14	1.08	1.08	0.54	0.36	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.93	5.56	5.56	0.52	0.31	0.62	0.10	0.00	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	58.46	3.73	11.41	0.70	0.47	0.00	0.23	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.15	3.52	1.60	0.00	0.32	0.32	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	45.65	1.13	3.94	0.56	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	49.74	0.19	6.31	0.93	0.74	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	35.78	0.66	5.27	0.44	0.44	0.00	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.95	1.98	4.25	0.28	0.57	0.57	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.24	0.76	7.58	1.52	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.01	2.96	3.62	0.99	0.33	0.00	0.66	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	17.49	0.00	1.88	1.01	1.16	0.00	0.29	0.14	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	15.99	0.00	0.60	0.00	0.30	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	9.95	0.24	2.84	0.47	0.24	0.00	0.24	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.07	0.00	1.34	1.00	0.84	0.00	0.33	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.01	0.28	0.00	1.10	0.28	0.00	0.28	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.84	0.25	0.74	0.74	0.50	0.25	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.69	0.00	1.37	1.96	0.00	0.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	17.80	0.00	1.25	1.07	0.36	0.36	0.18	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.96	0.00	0.65	0.87	0.22	0.00	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	19.67	0.23	1.17	1.17	0.70	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.40	0.00	1.06	0.53	0.53	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	0.00	1.11	1.11	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	21.87	0.45	2.08	0.89	0.30	0.00	0.15	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	23.15	0.40	1.20	1.60	1.40	0.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.74	0.42	0.62	0.21	0.62	0.00	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	26.08	0.00	0.92	0.69	0.92	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	25.33	0.00	1.58	0.68	1.13	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.97	0.44	2.18	1.31	0.87	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	10.22	0.27	1.61	0.54	0.27	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	19.02	0.17	1.22	0.52	0.87	0.35	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	0.42	1.26	0.00	0.00	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.78	0.00	0.92	0.55	0.92	0.00	0.18	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.36	0.00	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	0.00	0.88	0.88	0.88	0.44	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.43	0.00	0.87	0.35	0.35	0.00	0.17	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.75	0.00	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	11.64	0.00	1.51	0.43	0.22	0.65	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	10.24	1.23	2.05	2.05	0.82	0.41	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.92	0.23	0.70	0.70	0.00	0.00	0.00	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.06	0.23	1.39	0.00	0.23	0.00	0.23	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	15.48	0.00	2.40	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.93	0.46	3.46	0.23	0.00	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	12.56	0.65	2.60	0.43	0.00	0.00	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	33.32	0.31	4.67	0.47	0.16	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	10.83	0.17	2.97	0.70	0.17	0.00	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	19.40	0.89	4.91	0.89	0.45	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	16.33	0.00	2.55	0.00	0.26	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.73	0.00	2.42	0.00	0.22	0.00	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	11.37	0.00	1.26	0.00	0.00	0.00	0.00	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	12.20	0.00	5.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	7.25	0.00	3.11	0.00	0.00	0.00	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	16.52	1.07	3.20	0.53	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.01	0.00	5.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	9.13	0.00	1.40	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.84	0.00	1.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	25.48	0.00	8.22	0.00	0.00	0.00	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	23.94	0.73	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	28.78	0.50	7.57	0.00	0.00	0.00	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.55	26.26	7.27	1.62	1.21	0.81	0.81	0.00	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.99	19.97	6.39	0.80	0.40	0.80	0.00	0.00	1.60	0.00
CD34+ Progenitors, donor1	11545-120B6	14.06	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	33.15	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	9.77	1.50	3.76	1.13	0.00	0.38	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	14.66	5.86	4.96	0.23	0.00	0.68	0.00	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	46.06	3.21	13.93	1.07	0.00	0.00	0.36	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	55.11	1.22	9.80	4.90	0.61	0.00	0.61	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	29.28	1.52	7.32	1.22	0.30	0.00	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.51	4.08	4.34	1.02	0.51	0.51	0.00	0.00	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.84	2.02	2.92	0.22	0.22	0.45	0.22	0.00	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	13.51	3.45	4.31	0.29	0.00	0.29	0.00	0.00	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.34	1.42	5.22	0.00	0.47	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	0.00	6.32	0.00	0.00	0.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	0.00	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.67	6.50	6.65	0.72	0.87	0.29	0.00	0.00	0.72	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	12.88	4.41	5.59	0.85	0.17	0.51	0.68	0.00	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	22.25	6.29	5.00	0.97	0.32	0.81	0.00	0.00	0.32	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.97	0.45	2.24	0.00	0.00	0.00	0.00	0.00	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.19	0.35	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.92	1.32	1.76	2.20	0.00	0.00	0.44	0.00	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	7.17	3.79	6.75	0.84	0.42	1.26	0.00	0.00	0.00	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	6.23	2.70	5.82	0.62	0.00	0.83	0.21	0.00	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8.02	1.67	2.67	0.67	1.00	0.33	0.00	0.00	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	84.57	5.71	17.68	3.54	2.45	0.27	1.09	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	1.61	11.79	0.00	0.54	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	35.86	1.79	16.14	3.59	0.00	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	24.29	12.42	6.68	0.19	0.37	1.48	0.56	0.00	1.11	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	8.23	3.68	3.47	0.22	0.00	0.65	0.00	0.00	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	11.98	4.41	5.25	0.84	0.00	0.63	0.21	0.00	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	39.94	0.51	8.60	1.01	0.00	0.00	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	10.83	0.87	2.17	0.43	0.00	0.00	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.07	3.92	10.46	0.44	1.74	0.00	0.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	33.65	0.99	7.42	0.99	0.49	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.00	0.92	5.54	0.92	0.00	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	27.92	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	40.15	1.66	10.52	0.83	0.55	0.00	0.28	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	43.19	0.98	13.01	0.98	0.25	0.00	0.00	0.00	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	0.00	7.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	32.59	1.79	4.30	0.36	0.36	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	26.31	5.54	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	62.53	0.98	7.20	0.65	0.33	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	66.08	0.38	5.26	1.88	1.13	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	83.32	2.78	8.58	1.01	1.01	0.25	0.50	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.66	0.69	4.82	0.23	0.46	0.00	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.13	0.72	3.59	0.72	0.72	0.00	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	24.35	0.82	4.92	0.55	0.82	0.00	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	29.12	0.90	4.50	1.80	0.60	0.30	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	35.76	0.96	6.24	0.72	0.72	0.00	0.24	0.00	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.47	1.82	4.78	0.91	0.00	0.00	0.23	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.03	1.74	5.87	1.09	0.43	0.00	0.43	0.00	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.01	3.42	5.00	1.05	0.26	0.00	0.00	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	32.60	1.88	3.75	1.17	0.94	0.23	0.23	0.00	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.36	3.02	5.74	0.30	0.60	0.60	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	48.80	5.52	7.84	1.16	0.58	0.00	0.00	0.00	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	32.50	3.73	3.20	0.53	1.07	0.27	0.27	0.00	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	41.15	6.57	4.38	0.88	0.00	0.00	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	41.44	8.65	6.83	1.37	1.37	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	45.50	7.46	4.48	1.49	2.24	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.57	2.16	4.32	1.08	0.36	0.00	0.00	0.00	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	28.20	0.58	6.33	1.15	0.29	0.00	0.58	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	30.40	0.47	5.89	0.94	0.47	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	35.18	1.90	6.65	1.90	0.32	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	35.06	0.62	4.92	0.31	0.92	0.00	0.31	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.02	0.96	6.41	0.64	0.96	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.01	3.44	5.74	0.38	1.91	0.00	0.00	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	38.62	2.36	5.52	1.18	0.39	0.00	0.79	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	1.51	8.32	3.03	0.00	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	57.01	1.61	3.21	1.61	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	62.95	8.39	5.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	58.10	6.01	6.01	1.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	39.03	3.95	3.95	1.48	0.00	0.00	0.49	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	40.73	5.37	5.68	0.74	0.21	0.11	0.32	0.74	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	9.71	0.35	3.12	0.69	0.35	0.00	0.35	1.04	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	4.26	0.00	3.20	0.00	0.36	0.00	0.00	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	6.03	0.57	2.73	1.14	0.00	0.00	0.11	0.34	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	6.27	1.79	3.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.49	0.81	4.04	0.00	0.40	0.00	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	37.76	21.35	7.00	1.26	1.15	0.46	0.11	0.23	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	24.58	13.68	4.28	2.78	1.50	0.43	0.21	0.00	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	34.25	16.37	6.19	0.97	0.88	0.27	0.27	0.00	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	25.86	29.07	5.96	1.01	2.20	7.06	0.46	0.09	0.09	0.64
Corneal Epithelial Cells, donor1	11526-119I5	22.18	15.37	11.64	0.44	0.44	0.44	0.00	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	7.96	19.34	4.55	3.41	1.14	2.28	1.14	0.00	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	38.09	27.35	7.67	4.60	1.79	0.26	0.00	0.00	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.98	2.15	1.98	0.99	0.50	0.00	0.17	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	19.56	2.21	3.15	0.63	0.32	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.54	8.10	1.94	1.08	0.97	0.11	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.03	0.00	2.73	1.02	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	18.28	0.00	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	10.16	0.00	2.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	32.52	1.50	4.34	0.50	0.33	0.00	0.17	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	18.78	0.59	2.35	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	18.95	0.00	6.50	0.28	0.28	0.00	0.57	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	0.00	4.72	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	29.67	0.00	6.11	0.87	0.00	0.00	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	46.11	1.18	7.06	1.18	1.41	0.00	0.47	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	22.09	0.00	4.73	1.05	0.53	0.00	0.00	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.64	0.66	1.77	0.22	0.00	0.00	0.00	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.00	0.61	2.13	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	6.77	0.28	5.07	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	18.42	0.30	5.94	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	28.64	0.00	3.12	0.52	0.52	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.04	0.57	4.96	0.85	0.43	0.00	0.28	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	26.01	0.00	4.40	0.80	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	14.15	0.00	6.81	1.05	1.05	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	22.12	0.75	4.35	0.50	0.25	0.12	0.25	0.00	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.51	3.04	3.69	0.65	0.22	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.49	3.18	4.15	0.73	0.12	0.12	0.24	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	28.44	0.00	2.28	1.14	1.14	0.00	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	0.00	6.99	0.70	0.70	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	32.34	0.94	5.81	0.47	0.16	0.00	0.47	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	52.81	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	0.00	3.57	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	21.99	10.02	4.15	0.49	0.49	0.98	0.00	0.00	0.24	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	4.16	4.16	2.08	2.08	0.00	2.08	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.96	0.82	4.52	0.41	0.00	0.00	0.00	1.64	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.53	1.09	2.19	0.44	0.33	0.00	0.00	0.33	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.98	0.76	0.76	0.65	0.11	0.00	0.00	0.65	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.80	3.52	3.64	1.46	0.49	0.00	0.00	0.12	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.30	2.05	7.51	0.96	0.27	0.27	0.00	0.41	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.72	3.06	4.32	1.79	1.05	0.11	0.21	0.11	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	84.32	7.38	17.92	2.90	2.37	0.53	1.05	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	40.20	11.29	4.98	2.66	0.66	0.33	0.66	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	15.42	1.81	4.08	0.91	0.45	0.00	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	30.32	0.76	3.03	0.76	0.76	0.00	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	20.50	1.73	4.57	1.58	0.32	0.00	0.00	0.63	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	22.73	5.76	3.64	0.61	0.30	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	24.11	1.27	4.31	0.89	1.14	0.13	0.13	0.25	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	25.77	3.03	2.88	1.21	0.91	0.30	0.30	0.30	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.84	6.97	5.23	0.54	0.27	0.27	0.27	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.51	9.92	3.45	2.59	1.29	0.00	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	21.97	4.39	2.93	1.46	2.93	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	43.13	14.30	15.22	0.23	0.23	0.46	0.23	0.92	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	22.73	45.62	4.58	1.87	1.19	2.04	0.34	0.34	0.51	0.51
Fibroblast - Dermal, donor1	11269-116G9	20.90	4.93	3.29	1.88	0.00	0.00	0.00	0.94	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	23.11	2.36	8.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	19.34	10.52	5.44	1.57	0.48	0.24	0.36	0.60	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	24.64	9.04	6.78	2.49	1.02	1.81	0.45	0.34	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	15.53	4.71	6.80	1.40	0.87	0.35	0.52	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	19.82	5.68	6.98	1.30	0.49	0.49	0.49	0.00	0.00	0.32
Fibroblast - Gingival, donor1	11237-116D4	23.53	18.32	3.75	0.42	0.83	0.00	0.00	0.00	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.65	1.57	4.98	1.05	0.52	0.26	0.26	0.00	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	25.70	21.09	4.48	1.05	0.53	0.40	0.40	0.00	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	48.83	31.62	6.67	2.03	2.22	1.06	0.58	0.87	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	46.75	25.97	8.31	2.08	2.08	0.00	1.04	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	48.81	18.33	5.81	3.70	1.41	0.18	0.35	0.70	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	37.26	18.24	6.70	2.03	0.78	0.62	0.94	0.00	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.65	20.42	6.63	2.30	1.49	0.95	1.35	0.41	0.00	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	50.46	11.65	8.82	1.76	0.00	0.00	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	35.10	15.36	5.26	1.46	1.32	0.00	0.58	0.29	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	13.09	6.95	5.45	1.23	0.00	0.14	0.41	0.00	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.58	1.65	5.27	1.43	0.55	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.52	12.77	2.49	3.08	1.17	0.44	1.03	0.44	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	33.98	9.52	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	16.41	4.48	0.00	1.49	0.00	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	31.87	18.57	8.23	0.84	1.48	0.21	0.42	0.21	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	22.49	5.83	21.66	0.83	0.00	0.83	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	0.00	6.99	5.59	4.20	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.87	8.40	12.59	3.08	0.84	0.28	1.12	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	60.08	17.05	15.83	0.00	1.22	0.41	0.41	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	51.92	7.99	27.96	7.99	0.00	0.00	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	47.65	17.87	5.96	17.87	5.96	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.13	23.28	4.07	0.39	0.00	0.58	0.19	0.19	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.58	35.19	6.37	2.12	3.64	1.67	0.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.78	19.89	3.98	0.61	1.22	0.00	0.00	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	42.36	22.52	6.87	3.43	0.38	0.38	0.38	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	23.76	3.51	3.24	0.81	0.81	0.54	0.00	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	60.42	14.84	6.84	2.90	1.97	0.81	0.46	0.58	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.02	1.44	2.65	0.11	0.33	0.00	0.11	0.44	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	76.40	19.51	12.80	1.42	1.83	0.61	0.61	0.41	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	23.39	8.02	0.67	1.34	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.54	15.02	2.37	0.40	0.79	0.00	0.40	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	42.27	1.79	11.31	2.38	0.79	0.40	0.20	0.20	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.88	1.60	4.26	0.36	0.18	0.00	0.00	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6.50	0.79	2.96	0.59	0.39	0.00	0.20	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.60	1.20	9.93	2.41	0.30	0.00	0.90	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.33	1.73	1.94	0.65	0.22	0.11	0.00	0.11	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.32	2.28	8.10	2.28	0.76	0.00	0.00	1.77	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	9.19	2.46	3.45	0.66	0.33	0.16	0.16	0.33	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	47.12	2.21	13.83	0.20	0.20	0.40	0.20	0.00	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	16.38	0.70	5.12	0.80	0.70	0.00	0.20	0.20	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.88	1.51	11.79	1.21	0.00	0.00	0.60	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.74	4.06	4.64	0.58	0.25	0.00	0.17	0.66	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	4.62	5.47	3.93	1.03	0.51	0.34	0.34	0.17	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	34.16	1.97	9.20	1.31	0.00	0.00	0.99	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.82	0.85	2.24	0.53	0.11	0.00	0.11	0.43	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	9.11	1.18	3.88	0.67	0.34	0.00	0.00	0.00	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.14	1.41	1.10	0.78	1.10	0.16	0.00	0.78	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	36.60	22.66	6.97	3.49	2.61	3.49	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	45.07	5.55	3.64	0.87	1.04	0.00	0.52	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	42.16	5.99	4.94	0.78	0.52	0.00	0.52	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	63.88	8.18	4.34	2.81	0.26	0.26	0.00	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	0.77	10.72	1.53	0.77	0.00	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	20.42	1.91	7.66	0.64	1.28	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	20.82	0.57	7.13	1.14	0.29	0.00	0.00	0.00	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	11.31	1.65	6.62	1.38	0.28	0.00	1.10	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	7.31	1.14	3.65	0.68	0.00	0.00	0.46	0.23	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	25.36	0.59	6.34	0.99	0.40	0.00	0.79	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.90	1.32	5.29	0.53	0.53	0.00	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.78	0.33	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	18.13	0.44	9.29	1.33	0.88	0.00	0.44	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	23.60	0.42	7.49	0.57	0.57	0.28	0.14	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.84	0.37	6.65	0.74	0.74	0.00	0.25	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.15	0.00	5.37	1.88	0.00	0.00	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.37	0.25	4.34	0.37	0.12	0.00	0.12	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	16.33	0.42	6.23	0.42	0.28	0.00	0.42	0.00	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.08	0.20	4.68	1.22	0.20	0.00	0.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	13.69	0.68	3.88	0.91	0.68	0.23	0.00	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.57	0.50	2.62	0.62	0.37	0.00	0.25	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	14.21	0.00	3.93	0.00	0.66	0.00	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.59	1.18	2.07	1.18	0.30	0.00	0.30	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.90	0.95	2.38	0.48	0.32	0.00	0.00	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.97	0.67	5.14	1.12	0.22	0.22	0.00	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.91	1.41	4.23	0.81	0.40	0.00	0.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	10.52	0.68	3.22	0.51	0.00	0.00	0.17	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.42	0.71	4.61	0.98	0.09	0.00	0.09	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.39	2.08	8.43	1.66	0.42	0.10	0.42	0.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.39	1.37	4.95	2.05	0.85	0.00	0.17	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	12.84	1.66	2.21	0.33	0.22	0.11	0.11	0.11	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.48	1.00	4.24	0.42	0.25	0.00	0.17	0.42	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.21	0.41	5.31	0.41	0.00	0.20	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	11.97	1.65	2.89	0.83	0.00	0.00	0.41	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.88	0.35	2.19	0.35	0.00	0.00	0.12	0.12	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.34	1.17	4.67	0.83	0.67	0.17	0.33	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.34	0.88	3.75	0.66	0.22	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	10.58	0.61	2.58	0.49	0.37	0.00	0.00	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.64	1.13	3.73	0.16	0.32	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	8.98	2.25	3.21	0.64	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.66	1.04	1.90	0.76	0.47	0.00	0.09	0.09	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	14.87	1.42	4.43	0.79	0.00	0.00	0.00	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.68	0.91	1.82	2.43	0.91	0.00	0.30	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.14	0.52	2.20	0.84	0.10	0.00	0.21	0.10	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.88	0.66	1.54	0.22	0.22	0.00	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	9.54	1.96	1.40	0.28	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.81	1.76	2.69	0.74	0.37	0.00	0.00	0.09	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.71	0.00	2.67	0.80	0.27	0.00	0.00	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.29	2.60	2.75	0.92	0.31	0.15	0.46	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.71	2.72	4.66	0.13	0.26	0.00	0.13	0.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.13	1.36	1.36	0.54	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.56	2.40	1.84	0.18	0.37	0.00	0.00	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.26	3.29	1.97	0.44	0.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	17.85	0.99	0.99	0.99	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.11	4.09	2.11	0.92	0.26	0.13	0.26	0.13	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.70	5.25	2.02	0.81	0.20	0.00	0.20	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.23	2.29	8.13	0.25	0.25	0.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.67	0.00	5.77	0.40	0.60	0.00	0.20	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	29.43	0.15	4.31	0.15	0.62	0.00	0.00	0.15	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	29.46	1.02	8.59	0.41	0.00	0.00	0.20	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.78	0.63	8.14	0.31	0.00	0.00	0.94	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.91	0.28	5.93	0.85	0.57	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	26.75	0.00	6.92	0.46	0.46	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	0.00	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.53	0.39	3.48	0.39	0.00	0.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	0.00	4.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	5.22	8.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.90	1.95	1.95	0.65	0.98	0.00	0.65	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	17.71	0.82	7.00	2.06	0.82	0.00	0.00	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	0.00	10.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.62	1.68	6.43	1.40	0.00	0.00	0.28	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.26	1.96	5.56	0.65	0.33	0.00	0.65	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	23.49	1.68	5.03	2.52	0.84	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	19.40	2.54	5.09	1.27	0.95	0.00	0.64	0.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.70	3.74	4.08	1.02	1.36	0.00	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	2.09	2.09	0.00	0.00	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	17.75	0.00	4.58	0.57	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.35	1.48	4.44	0.59	0.59	0.00	0.89	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	0.00	3.39	1.69	1.69	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	30.24	4.97	4.97	0.83	1.24	0.00	0.83	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	25.77	5.98	6.90	0.69	0.23	0.23	0.23	0.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	0.00	5.27	0.00	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.61	5.77	6.15	0.77	0.00	0.38	0.38	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.91	3.26	5.87	0.65	0.33	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	6.02	4.68	1.34	0.67	0.67	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.57	3.85	4.24	0.77	0.39	0.39	0.00	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.09	3.08	2.05	0.68	0.34	0.00	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	0.00	2.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	12.27	2.36	3.77	1.42	0.47	0.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.07	4.83	3.02	0.60	0.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	11.19	4.58	1.53	0.00	0.51	0.00	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.94	6.38	4.79	0.40	0.40	0.80	0.40	0.00	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	16.77	2.47	1.48	0.99	0.00	0.49	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	3.54	1.18	1.18	1.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.67	1.75	5.25	0.58	0.58	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	12.29	3.51	1.76	0.44	0.88	0.00	0.88	0.00	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	23.74	4.24	4.24	0.00	0.00	0.00	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	1.79	2.98	1.79	0.00	0.00	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.04	5.82	3.88	1.46	0.97	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	2.28	4.57	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	6.65	4.57	0.42	0.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	1.12	2.25	2.25	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	27.59	7.61	1.90	0.32	0.00	0.63	0.63	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	28.41	20.89	3.76	3.76	0.42	0.00	0.00	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.46	36.67	8.47	2.55	2.09	2.20	0.70	0.35	0.23	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.41	33.42	6.92	2.87	1.69	1.18	0.84	0.51	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	33.67	39.13	5.23	2.05	2.73	1.82	0.91	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.80	34.54	6.12	2.84	2.84	1.31	0.66	0.22	0.00	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.61	33.74	9.46	1.72	2.15	1.07	0.00	0.64	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.49	31.22	6.03	2.37	1.72	1.08	0.65	0.22	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.00	34.87	3.86	3.11	1.87	1.87	1.00	0.00	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	29.34	29.34	4.12	1.72	1.89	0.86	0.86	0.00	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	27.87	34.60	4.49	2.88	0.96	1.92	0.64	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	0.00	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	26.40	0.43	5.63	2.16	1.30	0.00	0.00	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	0.00	0.00	0.00	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	33.86	13.76	5.29	0.71	1.41	0.35	0.00	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.79	9.44	5.09	1.45	0.73	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.55	5.42	5.59	1.57	0.17	0.17	0.00	0.52	0.17	0.17
Hepatocyte, donor1	11523-119I2	75.06	244.54	3.63	21.79	18.16	19.37	18.16	0.00	0.00	2.42
Hepatocyte, donor2	11603-120I1	68.95	128.20	8.62	25.86	11.85	7.54	5.39	1.08	0.00	2.15
Hepatocyte, donor3	11684-122I1	37.43	80.99	5.52	8.59	4.91	0.61	5.52	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	6.53	10.44	7.18	0.00	0.00	1.31	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	48.76	9.61	2.97	1.22	1.05	0.70	0.35	0.17	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.76	4.12	6.45	0.27	0.00	0.14	0.00	0.00	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	108.25	54.13	28.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	20.03	20.03	13.35	0.00	6.68	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	81.25	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	83.06	42.92	26.30	4.15	2.77	2.77	1.38	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	25.03	5.01	2.50	0.00	0.00	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	35.60	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	92.26	66.64	41.01	7.69	5.13	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	13.71	0.00	0.00	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	92.59	63.35	24.36	8.12	11.37	0.00	0.00	3.25	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	53.35	31.68	16.67	5.00	3.33	1.67	1.67	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	25.41	3.63	3.63	7.26	0.00	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	58.23	31.76	3.97	2.65	3.97	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	75.39	26.61	13.30	2.22	2.22	0.00	1.11	0.00	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	62.86	5.24	5.24	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	67.40	54.80	11.97	3.15	4.41	1.26	0.63	1.89	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	71.14	41.76	17.01	4.64	1.55	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	92.38	47.16	21.32	7.11	5.17	1.94	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	125.57	37.03	25.76	6.44	0.00	4.83	8.05	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	118.97	53.78	22.82	10.59	8.15	1.63	2.44	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	79.76	43.24	19.31	6.30	4.20	2.10	0.42	0.42	3.36	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	81.17	60.28	16.88	9.64	7.23	1.61	0.80	0.80	4.82	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	63.71	31.39	13.85	3.69	3.69	0.00	0.92	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	52.87	29.74	14.16	3.30	2.83	2.36	1.42	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	56.23	29.93	7.26	7.26	1.81	0.91	0.91	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	29.48	0.00	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	88.24	49.50	18.29	1.08	7.53	1.08	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	90.20	47.01	17.79	5.08	1.27	1.27	1.27	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	79.07	49.10	26.78	9.57	3.83	2.55	1.91	0.00	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	105.71	52.86	7.29	3.65	5.47	1.82	0.00	1.82	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	85.69	57.84	16.42	12.14	4.28	2.14	2.14	1.43	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	63.05	19.91	16.59	6.64	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	59.57	38.58	8.33	4.63	1.23	0.62	1.54	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	107.12	45.66	36.88	8.78	7.02	1.76	3.51	0.00	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	31.43	31.43	0.00	3.14	0.00	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	118.22	52.85	20.86	6.95	4.87	2.78	2.09	1.39	2.09	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	86.31	50.90	33.20	2.21	2.21	0.00	0.00	4.43	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	42.15	16.21	3.24	0.00	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	52.32	42.72	13.95	4.36	3.49	2.62	1.74	2.62	0.87	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	80.99	33.75	15.75	4.50	2.25	2.25	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	31.36	20.91	3.48	0.00	0.00	0.00	3.48	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	61.87	32.00	19.20	6.40	1.07	0.00	2.13	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	98.37	40.18	27.71	6.93	1.39	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	62.69	14.25	5.70	5.70	2.85	0.00	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	99.41	46.02	13.81	2.76	1.84	0.92	2.76	2.76	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	81.68	15.13	6.05	3.03	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	31.04	6.21	0.00	0.00	0.00	0.00	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	59.21	28.55	13.75	6.34	4.23	0.00	2.11	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	59.73	8.98	6.61	1.88	1.47	0.41	0.57	0.49	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	15.81	1.17	4.69	0.59	0.00	0.59	1.17	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	34.74	13.35	6.91	1.14	0.95	0.28	0.85	0.09	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	40.87	28.15	6.24	1.59	0.79	1.14	0.34	0.00	0.11	0.57
Keratocytes, donor1	11527-119I6	30.26	5.16	12.38	1.38	0.69	0.34	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	17.58	12.89	8.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	39.72	16.01	5.93	2.37	1.38	0.40	0.59	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	116.49	13.19	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	23.73	7.55	3.24	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.03	13.72	4.61	0.35	0.58	0.23	0.00	0.00	0.46	0.23
Lens Epithelial Cells, donor3	11690-122I7	39.76	3.23	8.98	0.30	0.20	0.00	0.20	0.10	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.23	1.30	4.86	0.47	0.36	0.00	0.12	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.70	0.28	3.63	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.02	0.79	2.36	0.47	0.31	0.00	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	1.08	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.09	0.95	2.84	0.63	0.32	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.86	0.54	3.88	0.97	0.32	0.00	0.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.21	0.82	1.64	1.64	0.00	0.00	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.86	1.01	5.81	0.76	0.25	0.00	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.20	0.70	3.94	0.00	0.42	0.00	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.10	0.79	6.33	0.40	0.00	0.00	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.83	0.58	5.62	0.39	0.19	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.03	0.37	3.89	0.56	1.11	0.00	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.01	1.05	5.23	0.35	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.78	0.72	6.20	0.72	0.00	0.00	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.34	0.82	3.57	0.82	0.14	0.14	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.16	0.00	2.46	1.23	0.00	0.00	0.92	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	0.31	2.81	0.00	0.00	0.00	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.41	0.55	5.31	0.91	0.18	0.00	0.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.56	0.99	4.61	0.99	0.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	11.42	1.17	4.69	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.69	1.00	4.73	2.49	0.75	0.00	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	0.00	5.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.89	0.00	3.50	0.54	0.27	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.05	0.45	6.81	0.76	1.21	0.00	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.63	0.00	4.67	0.52	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.38	0.63	4.61	1.05	0.00	0.00	0.00	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.44	0.45	3.91	0.75	0.30	0.00	0.00	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	0.00	1.38	1.38	0.69	0.00	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.09	0.75	4.70	0.75	0.38	0.00	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.63	1.17	2.65	0.74	0.42	0.00	0.00	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	0.00	3.39	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	0.66	3.64	0.00	0.66	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	16.35	0.74	4.21	0.50	0.62	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.51	1.48	7.40	0.00	0.37	0.00	0.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.66	0.25	4.94	0.99	0.25	0.00	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	15.40	0.69	3.99	0.55	0.41	0.00	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.75	0.96	4.82	0.00	0.32	0.00	0.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.00	0.61	4.26	0.30	0.30	0.00	0.00	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.74	1.26	5.60	0.14	0.14	0.00	0.14	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.53	1.07	4.62	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	0.48	4.85	1.45	0.97	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.54	0.31	5.45	0.47	0.47	0.16	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.10	0.36	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.11	0.00	2.61	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.83	0.24	3.06	0.24	0.24	0.00	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.85	0.50	7.05	0.87	0.50	0.12	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	0.77	3.59	0.77	0.00	0.00	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.53	0.30	6.27	0.60	0.30	0.00	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	31.72	4.53	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	38.36	57.53	6.14	3.07	3.07	3.84	0.77	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	31.92	37.85	3.71	0.00	2.97	2.23	0.74	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	34.70	28.77	5.50	5.08	0.85	1.27	2.54	0.00	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	46.42	54.16	7.03	4.22	4.22	4.92	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	31.75	40.16	5.60	4.67	1.87	2.80	1.87	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	25.76	25.76	4.64	8.24	5.15	3.61	1.55	0.00	0.52	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	39.25	55.90	1.19	5.95	1.19	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	34.61	30.31	6.33	2.94	0.90	2.26	0.23	0.68	0.90	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	28.50	23.85	5.53	5.82	2.62	1.74	0.00	0.00	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	30.16	42.77	5.85	4.05	4.50	1.35	0.00	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	51.08	41.87	10.57	5.15	2.71	2.71	1.35	0.41	1.35	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	36.46	32.35	4.62	7.19	3.08	4.11	1.54	0.51	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	40.93	37.40	5.29	2.47	0.71	1.06	1.76	0.00	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	44.64	39.31	2.67	6.00	3.33	2.00	0.00	0.00	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	39.22	26.49	7.13	7.13	3.57	4.08	1.53	0.00	0.51	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	41.35	50.69	4.27	5.07	3.20	2.13	0.80	0.27	0.00	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	45.54	45.91	6.42	8.88	3.97	3.59	0.94	0.00	0.19	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.34	33.75	4.29	10.43	3.07	3.07	0.61	0.61	0.61	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	55.45	65.23	8.15	4.89	2.45	3.26	4.08	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.69	36.44	1.87	6.25	3.96	1.87	1.87	0.21	0.42	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	29.43	22.70	6.45	8.13	3.08	2.52	0.56	0.00	0.84	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	43.27	48.43	4.12	8.24	3.09	0.00	3.09	1.03	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	41.51	34.26	4.35	8.13	3.77	3.77	1.74	0.29	0.29	2.61
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	29.30	19.13	2.69	3.89	2.39	2.09	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.79	46.47	6.64	3.87	3.32	3.87	1.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	50.55	54.79	5.30	8.13	4.95	3.89	2.47	0.00	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	33.93	20.28	7.38	4.06	4.06	0.74	0.37	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	26.48	8.06	3.45	1.15	1.15	0.00	1.15	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	42.98	37.99	7.29	5.37	5.76	3.07	1.15	0.38	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.27	28.87	7.93	5.66	2.83	4.53	1.70	0.00	0.57	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	34.46	12.31	2.46	2.46	0.82	1.64	0.00	0.00	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	53.77	38.41	9.04	3.16	4.97	4.52	0.90	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.14	25.14	6.46	2.87	1.44	0.00	2.15	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	43.32	38.84	1.49	5.98	1.49	0.75	2.24	0.00	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	50.54	28.98	8.92	8.18	3.34	5.95	3.34	0.00	0.37	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.86	12.49	4.31	6.03	3.45	1.72	0.00	0.00	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	55.66	41.96	3.43	4.28	1.71	0.86	0.00	0.86	0.00	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	45.65	35.65	4.33	9.00	3.00	2.33	2.00	0.67	0.67	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	23.53	17.50	7.24	7.24	2.41	2.41	0.00	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.99	34.84	2.13	2.84	0.71	2.13	0.00	0.00	0.00	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.53	41.25	6.19	5.50	2.41	2.75	1.03	0.69	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.54	23.62	4.29	4.83	4.83	1.61	0.00	0.54	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	40.40	45.12	4.04	5.39	2.02	0.00	0.00	0.00	0.67	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.86	41.12	8.52	5.56	3.33	4.44	1.85	0.00	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	11.63	1.16	2.33	3.49	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	37.02	3.17	4.23	1.06	1.06	1.06	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	41.62	44.02	7.60	5.20	4.40	4.00	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	33.44	9.45	3.63	1.45	2.91	2.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	64.39	63.62	4.60	2.30	1.53	1.53	1.53	2.30	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.35	63.14	7.89	7.40	3.45	2.96	1.97	0.00	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	29.17	16.94	4.70	5.65	1.88	0.94	0.94	0.94	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	47.77	64.36	7.04	3.52	2.01	3.02	0.50	1.51	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	54.07	48.67	3.60	9.91	6.31	6.31	4.06	1.80	0.45	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	18.93	3.44	15.49	5.16	6.88	1.72	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	44.09	54.33	6.23	3.12	2.67	3.12	0.45	0.45	1.34	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	52.40	46.92	6.26	5.87	5.87	2.74	1.17	0.39	0.78	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	33.65	25.07	3.30	8.58	5.94	1.98	3.30	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	54.49	65.90	6.75	5.19	2.08	3.11	0.52	0.00	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	52.51	43.32	4.81	8.75	4.38	3.06	3.06	0.44	0.44	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.31	17.89	4.47	4.47	1.68	2.24	1.68	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.53	50.35	5.30	5.74	2.65	2.65	1.77	0.44	0.44	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.53	46.29	5.79	6.94	5.01	3.09	0.39	0.77	0.00	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	32.41	20.76	2.53	4.56	2.53	3.04	0.51	1.01	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	50.95	50.95	5.77	5.77	1.44	4.33	0.96	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	46.12	42.14	5.96	3.58	4.37	2.39	2.78	0.40	1.19	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	28.56	22.48	6.68	10.94	2.43	2.43	3.65	1.22	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	48.42	21.44	4.15	6.23	2.08	1.38	0.69	0.00	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.92	47.88	7.60	3.80	4.56	1.52	2.66	0.76	0.76	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.40	18.59	6.71	6.20	4.13	5.16	0.52	0.00	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	64.09	28.42	7.86	4.84	2.42	1.81	1.21	0.00	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.39	39.93	5.39	6.34	2.54	1.58	0.95	0.00	0.63	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.38	23.46	8.00	5.86	3.73	0.53	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	65.51	14.37	9.19	5.75	1.72	2.87	0.00	0.57	0.00	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	58.62	45.25	6.17	6.17	1.54	4.63	3.09	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	53.05	14.15	4.95	7.78	2.12	2.12	0.71	0.71	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	56.18	22.70	10.21	2.27	1.70	2.27	1.13	0.57	1.70	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	63.65	39.52	6.24	5.41	2.91	1.25	1.66	0.83	0.00	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	46.98	16.44	2.35	4.70	9.40	2.35	1.57	0.00	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	67.64	21.29	7.93	3.34	1.25	1.67	1.25	0.00	0.84	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	64.58	32.52	4.65	3.25	1.86	0.00	3.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	42.15	12.04	6.69	6.02	4.01	0.67	0.67	0.67	0.67	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	68.97	21.92	10.69	5.88	3.21	1.60	0.00	1.07	0.00	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	55.77	29.50	6.87	4.45	3.23	0.81	1.21	0.81	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	29.37	20.19	4.59	1.84	1.84	0.92	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	52.46	21.34	9.78	6.22	2.67	3.56	0.89	0.89	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	67.24	34.19	11.97	3.42	2.85	1.71	1.71	0.00	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	45.25	18.41	12.27	5.37	3.07	1.53	3.07	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	77.15	26.81	7.66	4.38	2.19	1.64	1.09	0.00	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	59.69	33.85	9.35	4.90	4.45	2.23	1.78	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	55.11	24.70	8.06	1.82	2.60	0.52	0.78	0.52	1.56	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	68.30	19.89	11.27	7.96	0.66	3.32	1.99	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	51.97	16.63	10.39	6.24	4.16	4.16	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.45	3.42	3.87	0.46	0.23	0.23	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.06	1.65	2.02	0.18	0.00	0.00	0.18	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	15.60	8.52	4.19	1.05	0.52	0.13	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	3.19	0.53	0.00	0.53	0.00	0.00	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	18.86	1.74	4.28	0.63	0.32	0.32	0.32	0.00	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	31.83	3.34	3.61	0.56	0.69	0.14	0.00	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	45.54	2.99	6.38	0.80	0.30	0.20	0.10	0.20	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	19.40	10.71	8.40	0.87	1.16	0.87	0.58	0.00	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	32.43	10.48	5.24	1.75	1.00	0.50	0.00	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	66.44	17.63	4.07	0.68	1.36	0.68	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	86.30	24.98	10.71	7.68	2.70	0.76	1.73	0.00	0.00	0.22
Mast cell, donor2	11565-120D8	11.00	6.84	3.57	1.49	0.30	0.30	0.00	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	9.23	2.70	4.73	0.68	1.35	0.00	0.23	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	24.82	6.91	7.45	2.13	0.53	0.35	0.53	0.00	0.00	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	33.93	10.31	9.20	1.55	1.00	0.55	0.89	0.11	0.11	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	24.51	0.00	5.84	3.50	0.58	0.00	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	18.70	7.69	7.46	1.15	1.61	0.23	0.69	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	21.26	3.51	4.85	2.01	0.67	0.33	0.50	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	17.41	2.19	4.78	0.10	0.00	0.10	0.10	0.00	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	38.07	5.54	3.11	2.08	0.00	0.35	0.00	1.38	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	31.87	9.42	6.95	0.65	0.36	0.22	0.36	0.14	0.14	0.00
Melanocyte - light, donor1	11274-116H5	83.45	12.93	6.82	2.35	2.12	0.47	0.00	1.18	0.24	0.00
Melanocyte - light, donor2	11351-117H1	21.84	7.51	5.46	1.36	0.00	0.68	2.05	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	32.95	16.48	1.73	2.60	1.73	0.00	0.87	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	48.00	4.27	4.58	1.56	1.15	0.21	0.31	0.00	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	33.35	3.77	6.45	1.34	0.00	0.00	0.81	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	27.05	6.16	4.55	1.61	0.54	0.27	0.00	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	38.58	5.46	10.42	0.37	0.37	0.37	0.12	0.50	0.12	0.00
Meningeal Cells, donor2	11573-120E7	47.10	7.04	10.12	1.76	2.20	0.00	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	15.32	1.87	4.48	0.16	0.24	0.00	0.41	0.16	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.52	9.98	3.42	0.29	0.86	0.29	0.29	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.95	2.01	4.63	1.01	0.40	0.00	0.20	0.30	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	64.39	63.08	7.88	1.31	6.57	1.31	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	28.78	19.62	11.77	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	0.72	3.59	0.00	1.44	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.21	1.27	4.24	2.12	1.48	0.00	0.42	1.27	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	4.02	3.02	2.01	2.51	0.00	0.00	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	38.02	7.91	6.59	0.44	0.66	0.22	0.00	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	17.53	11.69	8.04	0.73	0.73	1.46	0.73	0.00	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.08	4.30	5.52	1.02	0.61	0.00	0.20	0.41	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	25.62	7.62	6.51	0.69	0.55	0.28	0.14	0.42	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	31.22	6.69	12.64	0.37	0.00	0.00	0.37	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	47.63	13.29	4.34	0.66	0.53	0.13	0.39	0.13	0.53	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	33.53	2.08	8.31	1.19	0.59	0.30	0.00	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.74	10.25	2.56	5.12	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.76	0.35	5.32	0.00	0.00	0.00	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	34.71	11.26	2.81	0.94	0.63	0.31	0.00	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.14	2.18	2.90	3.63	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	15.65	0.53	2.92	0.00	0.27	0.00	0.27	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	9.51	0.50	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.22	0.72	4.05	0.79	0.58	0.14	0.29	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	16.20	21.61	0.00	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.83	8.62	5.17	1.48	0.74	1.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	3.83	2.65	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	10.37	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.91	5.89	3.10	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.75	1.66	2.49	1.04	0.00	0.21	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	2.32	4.63	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	28.28	6.76	1.75	1.00	0.75	0.75	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.78	3.26	6.98	0.00	0.00	0.00	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	26.62	8.33	3.05	1.42	0.61	0.20	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.27	3.17	1.98	0.40	0.40	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	8.55	8.55	0.00	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	7.08	4.42	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	1.90	3.42	0.76	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	2.63	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.43	6.79	4.46	1.06	0.64	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	3.68	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	25.33	5.96	2.09	0.60	0.60	0.00	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	5.03	6.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.29	4.77	2.01	2.51	0.50	0.00	0.75	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	1.66	2.14	0.48	0.00	0.00	0.00	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.69	1.11	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.04	3.68	1.38	0.46	1.15	0.23	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.57	1.68	1.05	0.42	0.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	18.14	3.26	1.83	0.61	0.41	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.01	4.51	2.57	0.86	0.64	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.34	2.67	1.56	0.00	0.22	0.00	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.05	2.85	1.97	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	1.01	3.04	0.51	0.00	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.50	3.26	2.45	0.54	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.35	1.18	2.06	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	1.09	6.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	0.48	2.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	0.80	2.00	1.60	0.40	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	0.00	9.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	0.50	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	0.00	8.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	0.00	5.26	0.00	0.00	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	1.10	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	38.42	1.28	5.76	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.55	1.24	6.69	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	46.41	0.00	15.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	35.21	3.08	8.55	2.74	0.68	0.34	0.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.88	0.00	3.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	51.13	2.49	7.10	0.71	0.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.14	2.24	4.21	0.28	0.00	0.00	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.73	0.00	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	53.03	2.91	13.40	0.58	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	31.67	2.71	8.45	0.90	0.60	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.86	0.42	1.67	0.83	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	37.87	5.54	0.92	3.69	3.69	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	1.14	4.55	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	51.68	10.36	7.74	1.24	0.41	0.00	0.55	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.84	2.07	6.22	1.30	0.26	0.26	0.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.16	3.43	5.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	62.25	10.16	6.99	0.64	1.27	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	38.43	2.67	6.14	1.07	0.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.47	2.69	4.19	0.90	0.00	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	52.12	9.75	6.22	0.99	0.28	0.14	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	23.25	1.91	3.82	2.23	0.64	0.00	0.00	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.47	1.99	4.86	0.44	0.66	0.00	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	60.67	7.58	5.69	0.76	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	36.37	3.69	6.25	2.56	1.42	0.00	0.57	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.73	1.47	2.70	0.49	0.00	0.00	0.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.26	16.29	10.43	1.30	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	48.51	10.58	5.29	1.76	1.47	0.00	0.88	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.72	3.17	1.73	0.29	0.29	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	46.57	21.02	7.83	5.36	1.65	1.24	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	46.75	15.78	6.85	2.38	0.89	0.30	0.60	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	0.00	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.06	13.14	1.97	1.97	0.00	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	27.35	3.16	3.16	2.10	1.05	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.13	7.51	0.79	0.59	0.00	0.40	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	0.93	2.79	0.93	0.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.55	6.01	4.51	0.75	0.38	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	34.36	7.46	2.93	0.27	0.00	0.53	0.80	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.73	3.28	1.47	0.23	0.23	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	44.20	2.21	5.16	2.21	0.00	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	42.51	7.69	3.30	1.47	1.47	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	29.56	6.22	7.78	1.56	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	7.73	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	39.39	15.15	5.05	3.03	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.12	1.69	0.84	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	9.79	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.43	0.86	4.96	0.43	0.22	0.00	0.00	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.29	4.18	6.79	1.05	1.05	0.00	0.00	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.01	0.67	4.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.10	0.42	5.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.65	1.52	2.85	2.47	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	0.00	11.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	0.68	1.36	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	0.00	0.00	0.00	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	3.35	1.67	0.42	0.42	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.11	2.09	2.56	0.23	0.00	0.00	0.23	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.89	8.65	3.24	1.08	0.27	0.27	0.81	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.61	3.36	3.99	0.84	0.00	0.00	0.00	0.21	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	5.46	1.49	0.99	0.50	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.68	3.79	3.79	0.81	0.54	0.27	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	15.87	6.35	3.17	1.13	0.45	0.23	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.68	7.84	3.43	1.47	0.82	0.65	0.16	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	23.51	8.75	4.56	1.09	0.18	0.36	0.18	0.18	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.02	6.37	2.65	0.00	0.00	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	4.80	2.40	1.20	1.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.74	3.94	4.27	4.92	0.66	0.66	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.84	7.81	2.11	0.49	0.16	0.65	0.65	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.62	19.93	10.76	1.94	1.23	0.18	0.18	0.53	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	12.66	2.81	1.41	0.00	0.00	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.49	6.90	0.92	2.30	0.46	0.00	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.64	4.18	5.14	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.14	7.93	2.41	8.62	2.07	0.69	2.07	2.07	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	12.64	2.53	12.64	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	48.79	16.26	9.36	2.23	0.89	0.67	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	2.12	4.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	8.78	2.37	2.37	0.24	0.71	0.24	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.60	9.01	3.43	0.43	0.43	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.66	10.66	5.66	0.67	0.67	1.00	1.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	25.25	9.02	8.57	0.00	0.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.30	3.17	0.79	1.19	0.00	0.00	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	6.50	2.79	1.86	0.93	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	25.73	7.57	3.78	1.89	0.00	0.38	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.38	4.24	4.56	0.65	0.33	0.00	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	27.45	8.28	6.97	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	37.09	8.14	6.78	0.45	0.45	0.00	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	30.87	3.53	1.76	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.94	12.63	1.99	1.33	1.33	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.28	4.96	3.97	0.00	0.99	0.50	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	3.83	2.68	0.77	0.38	0.77	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.22	3.33	5.75	1.21	0.30	0.30	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	24.31	4.20	5.75	0.88	0.88	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	32.53	7.45	1.36	2.03	0.00	0.00	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	15.33	0.00	15.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	2.44	1.22	0.00	0.61	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.66	7.24	2.83	0.94	0.00	0.00	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.63	3.93	2.42	1.21	0.30	0.30	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	1.58	0.79	0.00	0.00	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	3.40	2.27	5.67	0.00	0.00	3.40	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	10.12	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	13.04	0.00	2.36	0.25	0.50	0.00	0.00	0.25	0.00	0.00
Myoblast, donor2	11322-117D8	36.44	2.69	5.95	1.53	1.15	0.19	0.38	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	4.88	0.34	2.02	0.50	0.17	0.00	0.00	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	74.28	28.60	5.40	1.31	0.44	1.17	0.29	0.00	0.15	0.29
Natural Killer Cells, donor1	11230-116C6	36.90	2.46	6.15	0.62	0.31	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	41.61	0.60	8.44	0.00	0.30	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	33.13	1.66	6.99	1.10	1.29	0.00	0.18	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	7.62	7.98	3.27	1.45	1.09	0.00	0.73	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	11.55	11.55	3.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	14.79	5.69	1.14	0.00	0.00	0.00	0.00	0.00	1.14	0.00
Neurons, donor2	11574-120E8	12.33	7.27	6.16	0.88	0.44	0.22	0.00	0.00	0.00	0.00
Neurons, donor3	11655-122E8	18.09	2.47	1.64	2.47	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	48.26	0.00	1.86	0.93	2.78	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	23.19	0.00	8.70	8.70	5.80	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	47.65	0.00	4.28	0.61	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	23.27	9.02	6.77	0.83	0.24	0.24	0.47	0.12	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	45.91	16.28	3.91	0.98	1.30	0.33	0.98	0.00	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	21.26	1.20	5.21	0.80	0.60	0.00	0.20	0.20	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	20.92	1.93	5.92	0.41	0.14	0.14	0.14	0.14	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	24.32	4.92	3.91	0.87	0.72	0.14	0.43	0.72	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	17.82	3.52	4.43	0.34	0.23	0.00	0.11	0.23	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	11.69	5.94	6.33	0.97	0.29	0.19	0.10	0.29	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	63.19	13.84	7.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.70	1.28	2.13	0.43	0.64	0.00	0.21	0.85	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	26.29	9.14	6.86	3.43	2.29	1.14	1.14	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	37.86	22.35	3.10	3.72	1.86	0.00	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	61.95	8.79	8.79	1.76	0.78	0.20	0.20	0.98	0.00	0.00
Osteoblast, donor2	11354-117H4	14.75	0.70	8.43	0.00	0.00	0.00	0.70	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	19.37	1.78	4.62	0.36	0.36	0.00	0.00	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	28.47	22.58	3.71	2.02	0.76	0.84	0.67	0.51	0.08	0.34
Pericytes, donor1	11491-119E6	30.15	16.02	10.13	1.67	0.45	0.33	0.45	0.89	0.22	0.00
Pericytes, donor2	11571-120E5	28.97	13.13	7.02	1.81	0.91	0.45	0.68	0.45	0.23	0.45
Pericytes, donor3	11652-122E5	43.95	6.51	7.32	1.63	1.63	0.41	0.20	1.22	0.00	0.00
Perineurial Cells, donor1	11499-119F5	24.41	10.28	7.69	0.79	0.23	0.11	0.00	0.34	0.11	0.00
Perineurial Cells, donor2	11579-120F4	53.18	6.53	4.97	0.83	0.46	0.18	0.28	1.01	0.55	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.50	0.32	9.24	0.96	0.32	0.00	0.32	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.63	0.73	5.63	1.47	1.22	0.00	0.49	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.09	0.26	6.47	1.04	0.78	0.00	0.13	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	13.39	0.48	4.30	0.72	0.24	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	21.07	2.22	6.65	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	22.38	11.58	7.85	0.79	0.59	0.39	0.39	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.71	0.00	2.22	0.63	0.00	0.00	0.00	0.63	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	8.07	0.19	2.81	0.75	0.56	0.00	0.00	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	23.23	0.65	5.09	0.13	0.65	0.00	0.00	0.13	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	12.38	0.23	3.38	0.90	0.45	0.00	0.00	0.90	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	16.20	0.64	4.37	0.64	0.96	0.00	0.53	0.85	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	10.48	0.87	0.00	0.87	0.44	0.00	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	9.31	0.29	2.44	0.14	0.14	0.00	0.14	0.57	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	14.76	0.00	2.95	0.00	0.98	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.97	3.69	6.45	0.31	1.23	0.00	0.61	0.92	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	27.27	3.01	7.08	2.48	0.89	0.18	0.71	0.18	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	22.82	2.89	6.64	1.87	0.85	0.00	0.17	0.51	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	29.25	6.71	6.99	0.75	0.37	0.00	0.09	0.47	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	23.01	3.68	6.90	2.76	1.84	0.00	0.46	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	9.72	0.73	5.43	0.84	0.73	0.00	0.21	0.10	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	48.12	2.87	2.56	2.56	1.51	0.15	0.91	0.15	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	20.99	0.54	3.52	3.25	2.03	0.00	1.08	0.00	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	48.62	2.57	3.80	1.78	1.41	0.12	0.43	0.43	0.06	0.06
Prostate Stromal Cells, donor1	11254-116F3	39.64	5.92	6.38	2.28	1.03	0.11	0.11	0.68	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	12.91	1.97	6.81	1.97	0.90	0.36	0.90	0.36	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	16.06	5.32	5.21	2.50	1.15	0.10	0.10	0.31	0.10	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	28.83	2.55	7.30	1.09	0.00	0.00	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.40	1.39	4.23	0.42	0.28	0.07	0.14	0.07	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	38.55	15.22	9.64	0.00	1.52	0.51	0.51	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	43.39	5.69	10.67	2.13	1.42	0.71	0.00	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	16.09	3.18	7.09	0.32	0.85	0.00	0.00	0.21	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	13.62	0.00	2.72	0.00	0.68	0.00	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.85	1.08	4.04	0.54	0.40	0.00	0.40	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.53	2.22	5.77	1.11	0.89	0.00	0.22	0.22	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	35.27	2.66	7.32	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	45.56	9.46	8.80	0.44	1.76	0.22	0.44	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	54.55	11.91	6.27	1.25	1.25	0.00	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	43.00	6.66	12.48	1.94	1.11	0.28	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.23	4.56	8.86	0.54	0.27	0.27	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	35.84	3.80	7.59	0.42	1.27	0.00	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	38.18	6.17	5.98	0.96	0.77	0.19	0.00	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.85	14.00	5.19	0.26	0.26	1.30	0.52	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.80	3.41	9.95	0.85	0.28	0.00	0.00	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	53.51	17.50	9.26	1.03	2.06	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.32	0.00	9.53	2.01	0.50	0.00	0.00	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	40.76	61.74	5.88	6.82	3.74	2.41	1.60	0.00	0.00	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	7.15	4.47	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.60	5.50	2.75	2.20	1.10	0.55	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.76	11.02	2.90	3.48	0.58	0.58	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.74	12.09	3.25	0.65	0.39	1.17	0.13	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	14.80	20.36	1.99	2.28	0.79	0.60	0.50	0.10	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	13.72	15.62	3.35	1.34	0.22	0.45	0.22	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.80	8.81	2.11	1.86	0.50	0.50	0.00	0.37	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	14.57	17.37	3.61	2.10	0.82	1.17	0.70	0.23	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.17	20.34	3.24	2.54	1.39	0.46	1.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	16.57	9.31	2.33	1.23	0.55	0.82	0.14	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.44	13.31	2.57	1.66	0.91	1.06	0.76	0.30	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	11.29	8.96	3.23	0.54	0.00	0.18	0.18	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.35	10.47	2.58	1.43	1.15	0.29	0.29	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.45	14.27	2.36	1.93	0.86	0.54	0.54	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	11.06	18.14	2.88	1.11	0.66	0.89	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.44	8.99	2.68	1.34	0.57	0.38	0.57	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.48	16.49	1.96	1.49	0.56	0.47	0.37	0.09	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	14.84	15.22	3.95	1.32	1.13	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.41	10.22	2.92	1.86	0.53	0.53	0.13	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	15.96	20.34	3.21	2.04	0.97	0.39	0.19	0.10	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.09	13.56	2.10	1.34	0.19	0.76	0.19	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.35	9.08	1.71	1.07	0.53	0.64	0.00	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	9.53	13.17	3.36	3.08	0.84	0.56	0.28	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	15.21	17.77	3.25	0.85	0.68	0.51	0.17	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	11.67	10.58	1.82	1.28	0.55	0.55	0.18	0.00	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.39	19.62	2.58	2.21	0.61	0.61	0.61	0.00	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.15	18.40	2.96	1.75	0.81	0.54	0.13	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.56	5.90	1.42	1.18	0.71	0.47	0.24	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.51	18.06	3.17	2.78	0.99	0.60	0.40	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.73	18.94	2.57	1.64	1.40	0.70	0.47	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.40	7.67	1.87	0.41	0.00	0.21	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	6.42	11.50	1.11	2.65	2.65	1.55	0.44	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	15.25	17.13	2.92	1.88	0.63	0.42	0.00	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.63	6.46	1.48	1.21	0.27	0.13	0.13	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.75	16.01	2.21	1.53	0.51	1.02	0.00	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.77	16.77	2.70	1.74	1.74	0.39	0.77	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.77	4.13	1.20	0.34	0.00	0.52	0.00	0.34	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.88	13.31	1.23	1.51	0.55	0.14	0.27	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	6.57	9.85	1.97	1.81	1.15	0.82	0.49	0.00	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.78	11.93	2.05	1.53	0.34	1.19	0.34	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.49	26.93	2.07	1.33	1.18	0.59	0.44	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.39	26.92	3.47	1.60	0.00	0.53	0.00	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.80	8.02	4.56	2.35	0.14	0.41	0.69	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	11.91	19.52	1.19	1.43	0.24	0.71	0.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.79	39.30	4.43	1.81	1.21	0.81	0.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.90	12.81	3.86	2.17	0.57	0.75	0.47	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.88	6.99	1.05	3.14	1.40	0.00	0.35	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	15.11	16.62	3.63	0.91	0.60	0.00	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	11.50	14.44	3.30	3.06	0.98	0.73	1.35	0.00	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	22.42	14.41	5.24	1.16	1.16	0.44	0.29	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	19.47	10.95	2.43	1.83	1.22	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.45	12.06	3.01	3.01	0.30	0.30	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	14.70	13.12	2.26	5.43	0.68	0.00	0.90	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.97	17.07	2.40	1.50	1.20	0.00	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.76	4.25	3.42	3.66	0.71	0.47	1.18	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	15.58	10.46	3.20	3.42	2.35	0.00	0.43	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	15.63	10.22	3.00	0.60	0.60	0.00	0.60	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	57.36	8.46	8.09	2.07	0.75	0.00	0.19	0.19	0.19	0.56
Schwann Cells, donor2	11578-120F3	51.04	0.00	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	27.82	7.23	3.72	1.31	0.66	0.44	0.44	0.22	0.00	0.00
Sebocyte, donor1	11220-116B5	75.04	5.48	11.50	1.64	1.10	0.00	0.55	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	68.01	4.60	11.49	2.76	1.84	0.92	0.92	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	51.94	29.47	6.60	2.68	1.24	0.21	0.62	0.41	0.21	0.21
Sertoli Cells, donor1	11255-116F4	33.13	0.00	9.94	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	0.00	5.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	17.07	0.26	5.89	0.88	0.53	0.00	0.00	0.53	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	26.02	1.45	7.23	2.17	0.72	0.00	0.00	3.61	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	17.56	0.84	10.03	0.00	0.00	0.00	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	19.64	7.38	4.08	1.73	1.41	0.00	0.16	0.31	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	26.76	9.22	4.91	1.34	1.04	0.74	0.45	0.30	0.15	0.30
Skeletal Muscle Cells, donor6	11459-119B1	15.39	1.85	6.31	1.08	1.08	0.31	0.31	0.15	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	54.69	24.07	5.17	2.14	1.01	0.63	0.50	1.01	0.38	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	28.11	21.69	4.85	2.43	2.28	0.29	0.57	0.43	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.32	5.56	6.15	0.50	0.69	0.00	0.10	0.20	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.23	3.62	5.14	0.67	0.34	0.17	0.25	0.93	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.23	0.72	10.13	0.00	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.03	3.03	4.68	0.69	0.83	0.41	0.28	0.14	0.14	0.00
Skin - palm, donor1	10286-104F7	34.92	16.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	24.36	2.16	3.46	1.15	0.00	0.14	0.29	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.99	4.09	17.18	1.64	0.82	0.00	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.71	4.93	4.54	0.78	0.39	0.52	0.00	0.13	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	28.50	0.83	4.17	1.67	0.42	0.00	0.56	0.42	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	54.43	2.39	7.31	3.52	0.56	0.28	0.84	0.14	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	64.28	26.01	15.01	1.27	1.06	0.63	0.63	0.42	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	42.35	1.80	7.12	1.57	0.82	0.00	0.45	0.22	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.39	0.62	1.54	0.62	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	80.93	0.89	20.90	4.00	0.89	0.00	0.67	0.67	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	30.57	1.76	5.29	0.00	0.00	0.00	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	39.56	1.77	6.63	0.22	0.22	0.00	0.22	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	0.00	3.54	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	28.58	1.55	3.86	0.00	0.77	0.00	0.00	2.32	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	3.00	5.00	0.00	2.00	1.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	24.22	0.40	5.46	0.40	0.27	0.00	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.18	0.66	5.76	2.66	0.89	0.00	0.44	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.89	0.00	2.56	0.38	0.51	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.33	5.54	2.60	0.00	0.00	0.33	0.00	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.47	2.95	2.95	0.89	0.00	0.00	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.93	4.98	3.56	0.43	0.71	0.00	0.28	0.14	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.63	11.55	7.81	0.33	0.33	0.33	0.00	0.33	0.00	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.14	22.53	3.96	1.52	0.91	0.30	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.77	2.02	10.86	0.00	0.00	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.66	0.00	9.54	1.43	1.91	0.00	0.48	0.95	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.35	5.90	3.83	1.03	0.15	0.15	0.15	0.00	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.28	12.05	5.60	3.66	1.72	0.22	0.65	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	20.36	9.34	4.51	1.57	1.15	0.63	0.52	0.31	0.00	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.11	0.46	5.26	0.00	0.46	0.00	0.00	0.46	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	0.00	4.31	4.31	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.23	0.00	4.18	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	57.01	12.29	11.95	1.02	0.34	1.02	0.00	0.00	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.24	10.29	4.40	0.31	0.39	0.39	0.24	0.16	0.00	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.06	1.31	3.62	1.11	0.70	0.00	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.77	0.00	6.37	1.59	0.46	0.00	0.23	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	0.00	5.43	0.00	0.60	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	30.73	2.65	7.15	0.53	0.26	0.26	0.79	0.26	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	43.01	8.12	7.19	2.13	0.27	0.53	0.27	0.80	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.19	7.14	5.76	4.26	1.50	0.13	0.88	0.50	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.76	13.70	2.54	1.78	0.76	0.51	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.31	0.75	4.98	0.45	0.00	0.00	0.15	0.30	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	3.00	7.50	0.75	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	492.33	0.00	7.75	3.88	1.29	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	21.86	0.93	7.44	0.93	0.00	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.61	0.00	4.04	1.01	0.00	0.00	0.00	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.66	0.00	4.70	0.31	0.31	0.00	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.06	8.55	5.01	0.59	0.88	0.29	0.59	0.29	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.66	11.00	9.58	0.17	0.08	0.58	0.00	0.08	0.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.64	35.04	6.07	1.87	0.47	0.00	0.47	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	19.29	0.00	4.03	0.43	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	28.30	2.29	3.06	0.00	0.51	0.00	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	26.51	1.69	5.08	0.94	0.56	0.00	0.94	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	24.04	6.57	6.71	0.98	0.84	0.00	0.14	0.14	0.28	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	23.13	2.51	7.96	0.25	0.34	0.00	0.08	0.34	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	0.00	3.81	1.43	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.33	0.73	4.40	0.24	0.24	0.00	0.24	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.58	1.55	3.09	0.44	0.22	0.00	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	35.11	18.73	7.31	1.46	0.59	0.59	0.00	0.59	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.46	11.86	4.47	1.36	0.78	0.39	0.58	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	31.21	4.76	7.67	1.06	1.06	0.00	0.00	0.53	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.79	4.09	4.46	2.98	1.12	0.37	0.00	0.00	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	18.69	4.67	4.31	1.44	0.36	0.00	0.36	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.67	0.28	1.14	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.18	2.76	2.76	0.00	0.00	0.00	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.14	1.02	6.35	0.76	0.00	0.00	0.00	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	10.38	0.80	3.99	0.80	0.40	0.40	0.00	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	22.57	5.02	3.76	0.84	0.42	0.00	0.00	3.76	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	37.13	11.00	5.04	0.92	0.46	0.00	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	8.42	0.34	2.86	0.67	0.17	0.00	0.17	0.34	0.00	0.00
Synoviocyte, donor2	11368-117I9	9.22	2.18	3.52	0.50	0.34	0.17	0.17	0.84	0.00	0.00
Synoviocyte, donor3	11440-118H9	5.59	0.67	2.90	0.22	0.00	0.22	0.00	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	49.31	30.37	11.08	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	0.00	17.84	1.98	1.98	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	84.51	35.20	12.50	1.16	2.08	0.93	0.93	0.69	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	25.95	4.16	6.52	0.93	0.79	0.00	0.14	0.07	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	37.50	13.92	6.57	2.32	0.39	0.77	0.39	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	48.68	4.58	5.73	2.29	0.57	0.00	1.15	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	43.67	54.87	5.29	6.03	2.83	1.97	0.98	0.25	0.00	0.86
Urethra, donor2	10319-105A4	25.18	12.59	3.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	42.24	2.13	6.91	0.53	0.53	0.00	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	37.25	4.01	3.61	0.80	0.40	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	36.67	10.54	4.81	2.06	1.15	0.92	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	34.10	4.90	5.80	0.22	0.00	0.22	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	17.80	0.89	5.34	0.00	0.00	0.00	0.00	0.00	52.50	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	14.30	0.00	7.15	0.00	0.00	0.00	0.00	0.00	45.75	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.22	1.37	8.90	0.00	0.68	0.00	0.00	0.00	5.48	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.14	0.69	4.82	0.00	0.00	0.00	0.34	0.00	16.53	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	24.40	0.58	2.91	1.74	0.00	0.58	0.00	0.00	20.92	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	0.00	6.25	0.00	0.00	0.00	0.00	0.00	24.99	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	10.10	0.92	3.67	0.00	0.00	0.00	0.00	0.00	52.31	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	13.69	1.83	4.56	0.00	0.91	0.00	0.00	0.00	7.30	0.00
Wilms' tumor cell line:G-401	10809-111A8	57.98	10.36	9.25	0.99	0.99	0.37	0.37	0.00	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	82.72	4.40	14.96	0.88	0.88	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	81.84	29.33	12.01	1.40	1.12	1.12	1.12	0.56	0.00	1.68
achilles tendon, donor2	10292-104G4	14.47	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	18.87	2.29	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	39.70	6.04	12.77	1.39	0.46	0.93	0.00	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	48.79	17.21	9.02	1.66	0.95	2.26	0.24	0.00	0.00	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	15.78	31.84	9.25	0.27	0.27	1.63	0.54	0.00	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	11.24	5.62	1.97	0.00	0.56	0.28	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	10.57	5.71	3.38	0.21	0.42	0.21	0.00	0.00	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	37.29	8.17	2.45	2.72	1.09	0.00	0.54	0.00	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.97	0.44	3.53	0.00	0.88	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	5.72	3.27	0.41	0.00	0.00	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	112.99	31.84	11.26	1.94	1.55	1.16	0.00	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.31	1.47	1.29	0.18	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	3.90	19.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	54.14	2.56	5.81	0.93	1.16	0.00	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.71	5.95	5.95	1.55	1.55	0.00	0.26	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.16	3.21	4.68	0.29	0.58	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	51.59	20.91	6.51	0.93	2.32	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.44	9.87	2.88	2.47	2.06	0.41	0.41	0.00	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.01	7.98	0.92	0.00	0.61	0.92	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	18.78	6.40	5.55	0.85	0.43	0.00	0.43	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	17.89	13.65	3.34	0.30	0.30	0.91	0.00	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.89	6.02	2.89	0.48	0.24	0.96	0.00	0.00	0.00	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.69	9.80	5.12	0.00	0.67	0.22	0.00	0.22	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	24.02	18.35	3.67	0.67	0.33	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	91.05	35.31	13.01	0.00	0.00	3.72	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	32.02	3.01	3.39	0.75	1.51	0.38	0.38	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.82	27.91	9.16	0.44	0.00	1.31	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	86.23	26.24	7.50	0.00	0.00	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	121.05	173.56	21.43	5.18	2.59	4.24	0.71	0.47	0.24	1.65
adipose tissue, adult, pool1	10010-101C1	11.94	21.25	2.95	3.10	0.78	0.78	0.62	0.16	0.31	0.16
adipose, donor1	10184-103D4	6.45	0.00	4.69	2.35	0.59	0.00	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	8.11	0.00	4.87	0.41	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	11.44	0.27	1.63	0.54	0.82	0.00	0.00	0.27	0.00	0.00
adipose, donor4	10187-103D7	6.93	0.00	3.47	0.87	0.87	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.67	31.09	11.05	0.95	0.63	0.79	0.79	0.00	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	54.57	141.87	0.00	0.00	14.55	7.28	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	37.62	66.57	4.00	2.00	1.20	3.20	0.13	0.00	0.00	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.09	17.51	17.15	3.22	0.36	0.36	0.36	0.71	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	11.13	0.70	4.87	0.00	0.00	0.00	0.00	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	2.70	6.09	1.35	0.68	0.34	0.34	0.00	0.34	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	6.48	0.29	4.12	0.29	0.29	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	15.42	28.46	3.56	3.56	1.19	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	22.71	66.30	3.24	3.04	3.24	1.22	0.41	0.00	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	18.72	2.90	1.94	0.65	0.00	0.00	0.00	0.97	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	24.07	1.53	3.44	0.51	0.13	0.00	0.00	0.13	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.24	0.00	5.96	0.22	0.44	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.40	9.69	14.36	0.33	0.33	0.67	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	12.36	9.02	3.92	1.18	0.20	0.39	0.00	0.20	0.20	0.00
appendix, adult	10189-103D9	29.50	8.15	3.49	2.72	0.78	0.00	0.39	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.76	9.29	8.60	0.34	0.34	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	24.46	29.89	1.36	2.72	2.72	2.72	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	29.70	22.31	4.06	0.58	0.58	0.29	0.00	0.14	0.00	0.00
b cell line:RPMI1788	10427-106D4	8.33	4.61	5.95	0.00	0.15	0.59	0.30	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.93	0.28	3.88	0.83	0.00	0.00	0.00	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	39.59	3.27	3.87	0.79	0.50	0.30	0.20	0.00	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	87.37	8.87	4.52	1.17	0.33	0.17	0.17	0.33	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	58.72	15.66	5.59	1.68	0.56	1.68	0.56	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	17.27	20.86	5.43	2.39	0.65	0.33	0.33	0.00	0.00	0.11
blood, adult, pool1	10053-101G8	24.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.86	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	0.00	4.28	0.00	0.00	0.00	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	14.85	4.05	1.35	2.02	2.02	1.35	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	18.45	42.03	4.10	5.13	1.03	1.03	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	14.03	62.92	2.78	3.23	2.12	1.34	1.22	0.00	0.11	0.22
brain, fetal, pool1	10085-102B4	8.01	21.37	13.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	56.49	37.33	9.25	0.99	1.32	1.65	1.32	0.00	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	146.67	270.37	11.98	5.62	4.87	7.11	1.12	2.00	0.62	2.87
breast, adult, donor1	10080-102A8	13.26	16.42	3.16	1.26	3.79	0.63	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	31.76	9.15	15.88	1.65	1.14	1.27	0.25	0.25	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	68.96	249.85	15.15	6.80	2.78	9.90	2.16	0.93	0.31	5.88
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.76	5.06	15.42	1.38	0.69	0.69	0.46	0.46	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	46.00	30.02	3.87	2.18	0.24	1.94	1.21	0.48	0.48	0.73
carcinoid cell line:NCI-H1770	10703-109H1	8.46	4.70	5.64	0.00	0.00	0.94	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	53.92	12.58	7.11	0.98	0.44	0.55	0.22	0.44	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	13.94	6.97	4.75	0.32	0.32	0.00	0.32	0.00	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	36.73	9.05	12.24	2.13	1.33	0.80	1.06	0.80	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	18.42	40.30	4.61	2.30	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	18.41	39.32	3.85	2.18	0.50	1.17	0.67	0.17	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	12.99	36.68	8.41	0.76	1.53	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.06	4.39	6.23	1.46	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	17.48	29.13	0.00	2.91	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	7.47	20.71	1.92	1.92	1.07	0.64	0.21	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	6.55	17.94	0.69	1.72	1.03	0.34	0.34	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	6.64	4.15	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	16.39	14.88	2.52	1.01	1.01	2.02	0.00	0.00	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	12.43	11.69	0.73	0.73	0.73	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	49.17	7.33	10.06	1.29	0.86	0.43	0.43	0.14	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	73.41	78.05	6.63	2.15	0.66	1.82	0.66	0.33	0.83	0.83
cervix, adult, pool1	10013-101C4	31.92	30.97	10.18	2.41	0.84	1.15	0.94	0.84	0.00	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	27.73	3.07	4.18	0.98	0.56	0.28	0.00	0.84	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	6.53	2.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.73	1.99	8.70	2.73	1.12	0.12	0.25	0.62	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	26.24	9.49	6.65	0.37	0.12	0.12	0.12	0.49	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	15.18	1.42	7.59	0.24	0.00	0.24	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	24.79	2.28	6.55	0.57	0.00	0.00	0.85	1.14	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	14.22	0.40	2.98	0.89	0.40	0.10	0.40	0.30	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	23.63	0.55	10.44	1.65	1.10	0.00	0.55	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	10.10	2.02	2.02	2.02	3.03	0.00	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.55	7.30	2.31	0.19	0.38	0.38	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	40.55	21.54	4.01	0.42	0.84	0.84	0.00	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	20.54	20.29	8.73	1.54	1.28	0.26	0.51	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.12	30.48	7.50	1.45	0.73	0.73	0.48	0.24	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.67	19.75	8.35	2.44	1.22	0.61	0.61	0.41	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	27.38	7.66	16.49	0.29	0.29	1.47	0.00	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	104.77	66.72	6.78	1.56	2.09	2.09	0.52	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.69	3.66	3.89	1.60	0.91	0.23	0.23	0.23	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	35.40	1.74	3.64	0.35	0.35	0.00	0.00	0.52	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	28.37	4.94	6.59	0.18	0.92	0.92	0.00	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	27.75	20.90	14.06	0.76	0.76	0.76	0.00	0.76	0.00	0.38
colon, adult, donor1	10082-102B1	20.23	16.66	5.95	3.57	3.57	2.38	1.19	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	37.60	24.32	5.88	3.41	1.76	0.82	0.59	0.12	0.12	0.47
colon, fetal, donor1	10070-101I7	13.60	6.80	5.56	1.24	0.62	0.62	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	0.00	18.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	75.64	1.70	9.35	2.12	0.00	0.00	0.42	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	58.26	8.00	8.75	1.81	0.45	0.30	1.21	0.00	0.45	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	71.07	12.55	10.01	1.41	0.99	0.99	0.56	0.00	0.42	0.42
corpus callosum, adult, pool1	10042-101F6	53.51	139.42	5.75	2.43	1.99	2.43	0.88	0.11	0.00	0.33
cruciate ligament, donor2	10295-104G7	47.01	8.10	4.86	2.43	1.62	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	29.69	20.87	4.82	0.00	0.80	0.80	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	24.48	49.92	2.16	3.36	2.88	2.64	1.20	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.49	5.28	8.50	2.30	1.61	0.23	0.23	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.64	16.93	10.77	0.51	0.51	1.54	0.00	0.26	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	120.36	12.28	11.55	1.93	1.44	0.24	0.48	0.24	0.72	0.00
ductus deferens, adult	10196-103E7	53.82	68.27	6.48	7.97	2.99	7.48	2.99	0.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	10.08	10.08	0.00	0.00	1.44	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.05	11.03	8.09	2.21	1.47	0.00	2.94	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	16.85	3.22	3.80	0.25	0.08	0.25	0.17	0.41	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.53	0.44	4.89	4.00	1.55	0.00	1.55	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	4.01	1.43	2.72	0.57	0.43	0.00	0.00	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	48.71	1.85	11.72	0.00	1.23	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	53.58	2.72	12.71	1.51	0.61	0.00	0.61	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	62.68	2.16	12.35	0.31	0.93	0.00	0.31	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	78.81	0.00	14.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	58.32	0.00	6.70	0.67	0.00	0.00	0.67	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	99.32	10.87	23.74	1.45	1.81	0.36	0.72	0.54	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.01	13.51	6.11	2.09	1.29	1.13	0.64	0.32	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	61.92	91.15	4.78	2.89	1.89	2.11	1.11	0.33	0.00	1.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	45.53	6.27	7.70	0.55	0.66	0.22	0.33	0.00	0.00	0.00
epididymis, adult	10197-103E8	51.70	37.89	7.12	11.51	4.81	1.47	0.84	0.21	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	120.99	23.60	22.35	3.02	0.71	0.53	0.18	1.06	0.00	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	37.75	2.75	5.90	0.39	1.18	0.39	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.56	29.88	5.37	2.36	2.49	1.05	0.52	0.26	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	61.51	30.61	6.89	3.25	2.46	1.57	0.59	0.98	0.00	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	49.07	31.37	5.49	1.90	2.58	0.78	1.12	0.34	0.11	0.22
esophagus, adult, pool1	10015-101C6	18.37	50.22	4.14	4.57	2.97	2.76	1.59	0.00	0.00	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	141.64	1.75	23.92	1.00	1.63	0.00	0.38	1.25	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	14.49	2.41	7.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	0.00	5.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	8.03	2.29	0.00	0.00	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	17.49	4.37	0.00	0.00	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	24.41	15.76	5.08	0.76	1.02	1.27	0.00	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	23.08	0.51	8.33	0.26	0.13	0.00	0.00	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.96	3.32	5.70	0.24	0.24	0.00	0.24	0.00	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	13.32	35.56	3.75	0.66	0.75	0.56	0.00	0.00	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	61.25	21.02	4.50	0.90	1.20	0.60	0.30	0.30	0.60	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	104.24	9.60	11.34	1.37	0.73	0.09	0.18	0.18	0.00	0.00
gall bladder, adult	10198-103E9	49.74	19.07	6.04	5.31	0.72	0.72	0.97	0.00	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	11.27	0.00	3.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	13.07	0.37	2.24	0.00	0.37	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	30.63	11.41	4.01	4.22	2.53	0.63	0.84	0.21	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	107.73	4.45	11.99	2.71	1.93	0.00	0.39	0.00	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	79.68	22.95	19.35	1.31	1.64	0.33	0.49	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	46.68	7.32	16.47	1.83	0.00	0.00	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	20.33	2.51	3.66	0.91	0.69	0.69	0.23	0.23	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	34.54	3.10	3.56	1.03	0.23	0.23	0.23	0.11	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	45.21	23.23	6.44	1.26	0.84	0.28	0.28	0.56	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	57.62	39.91	10.48	1.75	1.00	1.50	0.75	0.00	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	63.75	62.06	13.41	1.90	1.16	1.79	0.42	0.42	0.00	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	70.36	78.51	13.20	1.69	1.40	2.39	0.56	0.14	0.14	1.12
glioblastoma cell line:T98G	10485-107A8	42.05	24.72	6.51	0.88	0.66	0.22	0.33	0.44	0.22	0.22
glioma cell line:GI-1	10413-106B8	89.33	18.16	8.49	1.76	1.76	0.29	0.00	0.29	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	37.17	60.50	2.92	0.73	1.46	0.73	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	40.28	89.58	1.46	3.91	2.20	2.69	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	68.46	91.74	4.11	5.48	0.00	2.74	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	16.52	16.52	4.26	1.60	1.60	1.60	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	4.89	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.76	3.84	2.24	1.28	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	15.61	1.84	6.89	0.92	0.92	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.49	1.37	6.40	0.46	0.46	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	9.02	0.64	9.66	0.00	0.64	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	4.31	0.00	7.19	2.87	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	4.12	0.00	7.54	2.06	0.69	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	8.83	22.07	3.31	1.10	0.00	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	29.02	13.79	7.76	0.86	0.29	0.86	0.86	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	26.91	13.45	4.19	2.09	1.20	0.30	0.30	0.90	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	15.69	21.18	3.14	2.35	0.78	0.26	0.52	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	16.65	0.00	2.50	0.00	1.67	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	29.18	13.47	6.53	1.02	1.43	0.82	0.41	0.00	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	8.09	3.41	2.55	1.28	0.43	0.43	0.85	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	13.80	5.29	2.30	0.46	0.46	0.00	0.00	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	16.12	9.86	2.88	0.41	0.62	0.10	0.10	0.51	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.05	0.31	5.86	0.93	0.62	0.00	0.00	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	1.19	5.95	0.00	0.00	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	62.76	15.47	8.95	2.10	1.66	0.88	0.33	0.55	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	65.91	17.11	6.43	2.06	1.58	0.85	0.24	0.97	0.12	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	63.46	17.28	8.08	1.01	1.62	0.61	0.61	0.61	0.00	0.20
hepatoma cell line:Li-7	10484-107A7	77.18	6.45	3.11	1.56	0.78	0.00	0.11	0.22	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	42.01	20.90	8.64	0.70	0.30	0.80	0.40	0.10	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	16.09	23.66	4.73	1.89	0.00	0.95	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	20.82	64.50	3.47	3.88	2.04	1.02	0.61	0.00	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	5.98	13.44	3.49	0.00	1.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	7.40	4.23	2.47	0.70	0.00	0.70	0.00	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	18.31	0.00	4.27	2.44	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.71	0.20	5.89	0.20	0.79	0.00	0.39	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.77	0.51	5.08	1.02	0.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.07	1.13	5.64	1.13	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	10.33	0.52	5.16	1.81	0.77	0.26	0.52	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.18	1.14	5.69	0.38	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	5.26	1.46	4.67	0.88	0.00	0.00	0.29	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.52	0.43	3.02	1.08	0.65	0.00	0.22	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	4.59	1.67	2.50	0.42	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.10	3.55	2.60	0.47	0.24	0.24	0.24	0.00	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.02	4.50	7.07	1.61	1.29	0.48	0.16	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	0.67	4.04	0.67	0.00	0.00	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.96	0.00	5.79	0.31	0.63	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.25	0.49	5.90	0.98	0.49	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	0.00	6.11	2.62	1.75	0.00	0.87	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	9.16	1.72	7.64	1.53	0.76	0.00	0.38	0.38	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.47	1.31	6.54	0.44	0.44	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	9.00	1.00	4.50	1.50	0.00	0.00	0.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.85	0.38	4.33	0.75	0.94	0.00	0.38	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.73	0.45	5.46	0.00	0.00	0.00	0.45	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.28	0.00	6.26	0.00	0.00	0.00	0.31	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.84	1.14	2.94	0.82	0.49	0.16	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.13	0.87	3.48	0.29	0.58	0.00	0.00	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.67	0.60	6.28	0.30	0.90	0.00	0.90	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.04	0.18	6.10	1.66	0.18	0.00	0.74	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	15.41	0.00	6.85	0.29	0.00	0.00	0.29	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.70	0.41	8.98	2.04	0.41	0.41	0.41	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.80	1.41	3.52	1.06	0.00	0.00	0.35	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	8.55	0.63	5.07	1.58	0.32	0.00	0.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.26	1.21	5.45	2.42	0.00	0.00	0.61	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	2.07	5.69	0.52	0.52	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	3.32	0.00	5.31	0.66	0.66	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.24	1.28	7.18	1.03	0.26	0.00	0.26	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.80	1.79	3.58	1.28	1.02	0.00	0.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.84	0.00	5.30	0.00	0.76	0.00	0.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.40	2.02	4.70	1.01	0.00	0.00	1.01	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.77	0.00	6.52	0.97	1.45	0.00	0.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	16.04	0.00	5.79	2.23	0.89	0.00	0.89	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	14.15	0.00	9.27	0.49	0.98	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	6.11	0.92	6.42	0.92	0.00	0.00	0.92	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	3.25	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	5.96	0.00	4.30	1.32	0.33	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.21	0.00	5.47	0.00	0.00	0.00	0.55	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	8.69	0.36	6.15	0.72	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.91	1.07	0.71	0.00	0.00	0.00	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	0.00	4.77	2.39	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.62	2.03	4.47	1.22	0.68	0.27	0.27	0.00	0.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.62	1.89	6.47	0.54	0.27	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	37.53	0.48	3.63	0.48	0.73	0.00	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	30.10	7.92	0.79	0.79	0.79	1.58	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	19.21	41.45	4.45	1.04	0.47	0.66	0.19	0.28	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	83.24	17.56	8.78	2.93	0.65	0.65	0.98	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	24.43	12.62	5.31	1.30	0.80	0.00	0.60	0.20	0.00	0.20
kidney, fetal, pool1	10045-101F9	25.32	7.43	5.94	0.35	0.85	0.21	0.00	0.00	0.00	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.90	0.14	12.50	0.71	0.43	0.00	0.00	0.14	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	53.91	4.84	11.20	3.18	1.11	0.28	0.55	0.28	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.28	8.07	7.52	0.00	0.00	0.00	0.18	0.18	0.00	0.18
left atrium, adult, donor1	10079-102A7	20.70	16.35	3.27	4.36	1.09	0.00	2.18	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.56	2.02	1.01	1.01	0.51	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	50.34	5.75	13.68	0.27	0.55	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	12.93	4.67	3.95	2.51	1.44	0.36	1.08	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	6.52	0.54	1.63	0.00	0.54	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	12.38	1.70	4.86	1.46	0.73	0.00	0.24	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	62.73	5.23	6.27	1.05	1.05	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	68.83	5.55	6.49	0.59	0.47	0.00	0.12	0.35	0.24	0.00
liposarcoma cell line:KMLS-1	10782-110G8	56.55	3.75	8.75	1.56	0.62	0.31	0.16	0.62	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	45.81	21.08	5.48	0.73	0.61	0.24	0.37	0.61	0.00	0.00
liver, adult, pool1	10018-101C9	47.48	100.48	4.70	13.61	4.21	3.73	2.76	0.16	0.00	0.16
liver, fetal, pool1	10086-102B5	15.05	22.58	5.64	1.88	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.37	28.14	3.50	1.02	0.58	1.02	0.15	0.29	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	16.06	37.28	2.58	0.92	0.55	1.66	0.74	0.18	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	23.14	36.11	3.39	2.54	1.13	3.67	0.28	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	17.25	12.62	2.94	2.94	2.10	0.00	1.68	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	69.34	7.61	12.59	0.42	0.69	0.14	0.28	0.28	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	201.31	15.17	25.51	0.00	0.00	0.69	0.69	0.69	0.00	5.52
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	200.10	38.89	35.72	4.48	1.85	1.05	1.58	1.58	0.13	0.53
lung, adult, pool1	10019-101D1	20.32	14.06	4.37	1.65	1.06	0.24	0.35	0.24	0.00	0.24
lung, fetal, donor1	10068-101I5	36.82	5.14	11.70	1.43	0.29	0.00	0.57	0.57	1.43	0.00
lung, right lower lobe, adult, donor1	10075-102A3	39.41	13.29	5.50	7.33	1.37	0.00	2.29	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	29.82	7.57	8.05	3.79	2.84	0.95	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	53.04	28.05	8.55	1.10	0.88	0.88	1.10	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	33.96	7.40	2.26	1.21	0.45	0.45	0.45	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	185.19	12.74	7.65	2.55	0.85	0.00	1.70	3.40	0.00	0.00
mature adipocyte, donor1	12231-129F8	53.72	140.74	2.66	6.22	3.55	4.00	1.78	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	27.19	64.75	1.45	3.74	1.66	1.04	1.04	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	13.28	109.29	2.37	4.27	1.66	4.03	1.90	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	16.06	116.08	2.11	8.95	2.90	5.00	1.05	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	68.38	11.44	19.54	1.43	1.19	0.24	0.95	0.48	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	16.92	3.38	1.13	1.13	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	11.40	39.17	2.76	2.57	0.92	0.92	0.55	0.18	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	7.62	26.05	4.13	0.64	1.27	0.32	0.95	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	4.69	0.85	1.71	0.43	0.00	0.43	0.43	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	17.21	33.24	2.03	2.36	1.35	2.87	0.51	0.00	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	15.28	54.54	2.12	1.70	1.70	0.42	0.21	0.21	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	9.63	7.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	11.84	1.79	3.59	0.36	0.36	0.00	0.00	0.00	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	27.91	20.12	3.24	3.24	1.30	0.65	0.65	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	19.66	32.35	2.17	1.86	1.39	0.62	0.15	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	24.57	53.38	4.49	0.65	0.57	1.22	0.24	0.41	0.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	13.19	4.51	2.78	0.00	0.35	0.35	0.35	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	10.18	1.99	5.31	1.33	0.44	0.00	0.44	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	69.57	18.59	11.86	0.37	0.49	0.49	0.49	0.12	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	103.64	5.17	9.20	3.45	1.87	0.29	0.72	0.14	0.14	0.00
melanoma cell line:G-361	10465-106H6	11.67	0.54	5.70	0.81	0.54	0.00	0.27	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	16.46	0.36	2.89	0.54	0.72	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	58.16	89.88	12.34	9.69	5.29	6.17	3.52	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	23.85	43.29	6.74	3.89	1.81	1.81	0.26	0.00	0.78	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	17.64	2.76	3.38	0.46	0.77	0.77	0.00	0.31	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.63	1.09	3.64	0.91	0.36	0.00	0.18	1.09	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.52	1.24	2.90	0.00	1.24	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.11	2.95	2.81	0.70	0.00	0.00	0.14	0.28	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	21.38	4.04	2.50	0.58	0.19	0.19	0.58	0.77	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	3.47	2.78	2.08	0.00	0.69	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	16.48	0.51	3.09	1.03	0.34	0.00	0.17	0.51	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.38	4.26	4.49	1.15	0.23	0.35	0.12	0.69	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.40	1.86	4.51	1.06	0.40	0.00	0.13	0.27	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.64	0.95	3.38	0.27	0.00	0.00	0.00	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.08	1.00	3.98	0.43	0.28	0.00	0.14	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.48	2.96	5.93	2.31	0.66	0.00	0.66	0.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.65	0.83	3.87	0.28	0.00	0.00	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	7.33	0.70	4.54	0.70	1.05	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.37	0.61	3.47	0.20	0.00	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.14	0.00	5.75	1.44	1.08	0.00	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.93	0.72	3.41	0.83	0.31	0.00	0.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.00	0.46	2.96	0.68	0.46	0.23	0.00	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.65	0.00	1.68	0.42	0.84	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.77	0.30	1.64	0.15	0.00	0.00	0.00	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.48	2.28	3.59	1.14	0.44	0.09	0.35	0.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.57	1.47	4.05	0.74	0.00	0.00	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.59	0.00	5.72	0.86	1.43	0.00	0.00	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.84	0.42	2.11	0.42	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	4.11	5.02	1.83	0.46	0.00	0.00	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	2.81	6.14	1.28	1.02	0.00	0.26	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.04	4.19	4.45	1.31	0.26	0.00	0.00	1.05	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.10	4.01	4.01	0.62	1.23	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.06	2.82	3.53	2.12	1.18	0.24	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.15	3.05	4.74	1.69	0.34	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.58	5.11	4.32	0.39	0.79	0.00	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.95	2.32	4.63	1.39	0.00	0.00	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.32	3.17	4.61	1.73	0.87	0.00	0.00	0.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.94	2.68	2.90	0.67	0.45	0.22	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.74	3.12	3.61	0.00	0.48	0.24	0.24	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	7.33	3.67	0.00	0.73	0.00	0.00	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.73	3.69	4.36	0.67	0.67	0.67	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	1.23	2.46	0.82	1.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.31	2.15	3.01	0.00	0.43	0.00	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	5.47	0.00	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	2.92	3.57	0.65	0.65	0.32	0.00	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	2.91	2.91	0.00	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.40	4.26	2.13	1.07	1.60	0.00	0.00	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	1.64	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	1.94	2.33	1.94	0.00	0.00	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	0.99	0.99	0.00	0.99	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	2.37	2.96	0.59	0.00	0.00	0.00	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	2.44	1.22	1.22	0.00	0.00	0.00	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.70	1.27	2.53	0.63	1.27	0.00	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.21	2.07	1.03	1.03	0.34	0.00	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	4.30	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.41	1.22	1.63	0.00	0.00	0.41	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	2.38	5.56	0.00	0.00	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	14.74	1.77	0.59	0.00	0.59	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	11.22	3.12	1.25	0.31	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	16.04	2.67	1.34	0.00	1.34	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	46.12	0.00	0.00	1.18	3.55	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	28.25	0.00	5.14	5.14	2.57	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	51.63	0.69	4.13	0.69	1.38	0.69	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.84	174.17	0.49	8.41	7.92	8.91	1.48	1.48	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	174.96	0.00	8.97	6.73	3.36	4.49	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	17.17	139.30	1.27	6.36	6.36	5.72	1.91	0.00	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	187.79	0.40	8.46	6.04	6.04	3.22	0.40	0.00	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	209.34	0.00	8.72	8.72	21.81	4.36	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	217.93	1.27	13.94	7.60	13.94	3.80	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	69.79	1.21	4.25	3.64	3.03	1.82	2.43	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	31.63	0.00	13.56	0.00	4.52	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	71.66	0.82	7.41	5.77	4.94	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.31	45.04	1.79	1.98	2.58	3.77	0.79	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.98	73.98	1.95	6.17	3.57	6.81	1.95	0.65	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	98.81	4.07	2.04	4.07	3.06	3.06	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.17	4.64	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	122.61	160.64	12.76	2.13	2.60	4.49	0.71	0.47	0.47	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	46.33	10.89	4.87	0.46	0.00	0.23	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	31.34	14.39	5.24	0.82	0.82	0.92	0.31	0.10	0.31	0.21
mesothelioma cell line:Mero-25	10850-111F4	18.16	0.00	4.31	1.59	0.45	0.00	0.23	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	9.29	1.22	2.93	0.24	0.24	0.00	0.00	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	9.08	0.89	3.54	0.22	0.00	0.00	0.22	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	36.53	1.05	7.36	1.31	0.26	0.00	0.00	0.79	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	50.22	16.34	8.51	2.55	0.68	0.68	1.02	0.00	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	30.08	7.84	6.82	1.77	0.25	0.25	0.51	0.51	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	10.56	7.66	6.00	1.45	0.41	0.21	0.21	0.00	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	13.42	0.66	5.30	0.33	0.50	0.17	0.33	0.17	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	20.63	3.62	5.25	1.63	0.90	0.00	0.72	0.00	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	20.50	15.89	6.32	2.39	1.54	0.85	0.68	0.68	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	28.50	1.02	5.85	0.76	1.27	0.00	0.51	0.25	0.00	0.00
mesothelioma cell line:No36	10857-111G2	21.53	9.13	4.24	0.65	0.98	0.98	0.33	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	16.80	9.21	4.61	2.98	1.90	0.27	0.81	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	6.91	0.38	3.26	0.19	0.77	0.00	0.38	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	24.42	0.85	3.42	0.37	0.24	0.00	0.37	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	12.03	0.00	2.87	0.00	0.18	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.34	0.98	1.96	0.98	1.31	0.00	0.33	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.30	8.05	3.81	2.12	1.06	0.64	0.42	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	94.91	0.23	9.44	0.23	0.00	0.00	0.23	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.79	6.66	4.95	0.76	0.19	0.00	0.19	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	67.63	13.12	4.99	1.29	1.85	0.55	0.18	0.18	0.18	0.18
myeloma cell line:PCM6	10474-106I6	70.96	11.86	5.73	0.99	0.20	0.20	0.20	0.00	0.59	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	84.21	40.08	14.71	2.03	0.51	1.52	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	55.51	12.36	7.26	1.57	0.98	0.00	0.78	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.95	1.56	2.67	0.22	0.11	0.00	0.22	0.45	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.81	1.32	2.65	0.37	0.51	0.00	0.15	0.15	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	41.40	7.18	6.07	1.10	0.00	1.66	1.66	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	26.92	3.45	19.10	0.46	0.23	0.00	0.00	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	39.85	21.33	13.66	0.56	0.00	0.75	0.37	0.00	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	13.29	4.43	3.37	0.00	0.21	0.21	0.00	0.00	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	9.50	0.93	2.80	0.37	0.19	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	21.35	2.14	18.03	1.19	1.42	0.00	0.71	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	22.01	8.39	9.50	2.06	1.27	0.16	0.95	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	24.96	9.46	12.28	0.40	0.81	0.40	0.20	0.00	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.17	8.90	22.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.91	0.27	4.26	0.27	0.00	0.27	0.00	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	50.06	22.66	13.02	1.69	0.85	2.71	0.34	0.00	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	9.61	3.20	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	4.49	1.60	1.28	0.64	0.64	0.00	0.00	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.29	0.79	3.68	1.05	1.84	0.00	0.26	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	20.81	50.34	4.03	1.03	0.84	1.31	0.09	0.00	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	18.54	37.09	4.12	2.06	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	19.05	54.75	4.56	1.61	3.22	0.54	0.27	0.27	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	15.29	0.73	4.37	0.36	0.00	0.00	0.36	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	16.79	36.74	4.72	6.30	3.94	0.26	1.84	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	17.59	9.01	3.86	0.86	1.29	0.00	0.00	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	15.69	41.16	6.78	0.24	0.39	0.63	0.24	0.08	0.00	0.08
olfactory region, adult	10195-103E6	16.05	56.17	2.48	3.06	1.91	0.57	0.96	0.00	0.00	0.19
optic nerve, donor1	10277-104E7	28.01	82.04	6.00	12.01	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	158.90	76.43	6.04	6.49	2.96	2.39	0.91	4.67	0.11	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	57.43	50.42	9.20	1.51	1.92	0.82	0.41	0.14	0.00	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	62.65	65.70	6.94	12.87	8.97	6.26	3.89	0.00	0.00	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.46	3.58	10.97	0.58	0.35	0.00	0.12	0.00	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	6.76	0.59	3.23	0.59	0.29	0.00	0.00	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	193.41	12.15	29.90	0.93	0.00	0.00	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	112.39	31.60	5.09	2.12	0.64	1.06	0.85	0.00	0.21	0.00
ovary, adult, pool1	10020-101D2	37.47	40.09	7.25	5.42	0.79	0.26	1.05	0.09	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.73	0.73	2.75	0.37	0.00	0.00	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	8.47	3.76	4.70	0.00	0.94	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.99	9.78	12.86	1.68	0.56	0.28	0.28	0.28	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	31.69	8.01	2.90	2.90	2.04	0.51	0.68	0.17	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	72.03	3.81	9.60	0.99	1.16	0.50	0.17	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	11.26	32.22	3.75	0.46	0.46	0.37	0.27	0.18	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	7.34	23.49	2.94	2.20	0.00	0.73	0.73	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	8.46	23.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	8.27	27.65	3.42	2.28	1.43	1.71	0.86	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	15.51	39.48	5.02	0.26	0.35	0.62	0.09	0.00	0.00	0.18
parietal lobe, fetal, donor1	10072-101I9	12.61	13.58	13.58	2.91	0.97	0.00	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	12.71	1.12	3.36	0.75	0.00	0.00	0.00	0.37	0.00	0.00
parotid gland, adult	10199-103F1	18.50	49.95	4.93	8.02	0.62	4.93	0.62	0.00	0.00	0.00
penis, adult	10200-103F2	24.17	15.04	2.69	2.69	1.61	2.15	1.07	0.54	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	25.47	5.02	22.31	1.86	1.12	0.00	0.37	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	72.85	16.61	7.14	1.46	1.31	0.15	0.00	0.00	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	29.03	3.87	12.26	0.65	0.65	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	14.81	1.18	4.15	0.00	0.59	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	11.91	11.91	6.90	0.63	0.63	0.00	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	18.21	5.06	4.05	4.05	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	28.14	18.24	11.47	1.56	1.04	1.04	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	20.43	28.94	16.17	8.51	2.55	3.40	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	44.18	4.41	19.24	1.61	0.22	0.11	0.11	0.11	0.00	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	10.59	2.65	3.97	0.66	0.40	0.00	0.26	0.13	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	35.33	29.88	4.20	0.47	1.40	0.47	0.31	0.00	0.00	0.47
pons, adult, pool1	10033-101E6	12.05	32.53	3.53	0.52	0.09	0.52	0.17	0.00	0.00	0.00
postcentral gyrus, adult, pool1	10032-101E5	13.77	38.44	5.06	0.61	0.61	0.52	0.44	0.00	0.00	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	2.09	16.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.24	12.82	5.10	0.58	0.29	0.58	0.15	0.15	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	41.38	9.62	6.17	0.54	0.73	0.18	0.18	0.54	0.00	0.00
prostate, adult, pool1	10022-101D4	18.86	17.50	5.53	1.00	0.82	0.27	0.18	0.18	0.09	0.09
putamen, adult, donor10196	10176-103C5	18.18	57.13	3.30	1.89	1.65	1.65	0.24	0.00	0.00	0.24
putamen, adult, donor10252	10152-102I8	13.73	13.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	3.28	3.28	0.00	1.09	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.21	25.85	2.42	2.17	1.21	0.48	0.24	0.00	0.00	0.24
putamen, newborn, donor10223	10365-105F5	9.75	1.50	3.00	0.75	0.00	0.75	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	89.61	5.24	8.15	0.87	0.00	0.58	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	34.77	8.35	8.35	2.78	0.00	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.61	11.45	8.90	1.06	1.27	0.21	0.42	0.64	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	12.01	0.41	2.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	46.52	30.62	10.24	1.29	1.39	0.80	0.50	0.30	0.00	0.40
retinoblastoma cell line:Y79	10475-106I7	12.47	2.34	16.63	0.52	0.52	0.52	0.26	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	101.80	42.29	13.16	2.21	1.11	1.35	0.37	0.12	0.25	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	196.56	34.59	29.24	1.97	0.56	0.00	0.00	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.23	5.30	4.55	0.00	0.76	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	14.24	15.54	6.15	1.94	0.32	0.16	0.16	0.00	0.00	0.65
salivary acinar cells, donor2	11772-123I8	5.51	2.20	2.89	0.41	0.14	0.14	0.14	0.00	0.00	0.00
salivary acinar cells, donor3	11773-123I9	23.17	17.88	7.94	0.00	0.00	0.00	0.00	0.00	0.00	1.32
salivary gland, adult, pool1	10093-102C3	16.59	60.63	6.86	1.14	2.86	5.72	0.57	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	31.20	2.95	8.60	0.67	0.51	0.00	0.34	0.25	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.14	3.88	8.82	0.82	0.24	0.12	0.00	0.47	0.00	0.00
seminal vesicle, adult	10201-103F3	50.79	75.66	5.29	12.70	7.41	5.29	4.23	0.00	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	34.74	16.52	3.16	4.37	2.67	0.49	0.49	0.00	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.54	1.26	0.25	1.26	0.25	0.00	0.00	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	0.00	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	31.70	4.43	3.22	0.54	0.13	0.13	0.13	0.13	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	57.81	10.17	7.63	1.22	0.77	0.66	0.44	0.44	0.11	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	60.00	28.64	8.64	1.94	1.16	2.06	0.52	0.26	0.13	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	4.97	9.93	0.00	0.00	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	29.26	18.35	10.19	3.12	0.72	0.60	0.96	0.12	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	22.11	17.09	6.03	3.02	0.00	0.00	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	40.71	6.79	6.79	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	26.51	68.80	6.31	3.79	4.42	1.26	1.89	0.63	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	19.01	51.03	4.00	1.00	0.00	2.00	0.33	0.00	0.00	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.66	4.10	13.55	1.58	0.63	0.63	0.95	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.28	1.93	4.82	0.39	0.39	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	55.05	1.15	14.18	0.82	0.33	0.00	0.33	0.33	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	12.71	7.56	12.39	1.29	0.00	0.00	0.48	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	17.87	1.96	3.49	0.44	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	79.67	51.72	10.51	7.05	4.06	2.87	2.03	0.00	0.12	1.43
small intestine, fetal, donor1	10064-101I1	47.42	11.30	9.34	2.21	1.23	0.98	0.74	0.25	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	42.06	2.56	1.54	2.56	1.03	0.00	1.03	1.54	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	13.70	12.15	2.58	0.26	1.03	0.52	0.52	0.78	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	112.57	1.07	12.33	0.27	0.00	0.27	0.80	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	33.26	41.75	3.67	4.13	2.52	2.75	0.46	0.23	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	20.90	28.39	4.73	0.79	0.79	0.00	0.39	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	11.07	44.27	3.46	3.46	2.77	0.69	2.08	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	28.66	32.93	6.10	1.83	2.44	0.61	0.61	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	16.99	3.67	1.38	0.92	1.38	0.46	0.00	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.19	0.15	7.62	0.60	0.00	0.00	0.00	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	25.44	2.31	4.74	1.65	0.77	0.00	0.22	0.11	0.11	0.00
spleen, fetal, pool1	10044-101F8	24.00	4.13	4.05	0.24	0.40	0.08	0.08	0.00	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.91	3.42	5.38	0.41	0.31	0.31	0.00	0.00	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	79.18	6.27	11.96	0.00	0.57	0.19	0.38	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	49.97	26.21	18.17	6.64	2.45	4.19	1.75	0.00	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	69.59	0.00	4.69	0.78	0.39	0.00	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	99.16	7.77	7.32	0.90	1.58	0.34	0.34	0.45	0.11	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	28.38	5.93	7.62	1.69	0.85	0.00	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.00	6.77	9.31	0.85	0.85	0.00	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	24.56	1.07	5.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	45.57	47.85	2.85	5.13	6.27	3.42	1.71	0.00	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	27.00	82.87	1.66	3.32	2.70	1.04	0.42	0.00	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	7.76	31.55	3.10	2.07	0.00	1.03	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	12.72	6.36	1.41	0.00	0.71	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	51.13	10.32	17.88	1.60	0.00	0.69	0.00	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	23.14	70.87	5.34	2.71	1.27	1.10	0.93	0.00	0.00	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	12.82	12.82	9.26	0.71	2.14	0.71	0.71	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	9.23	8.35	6.59	0.00	0.44	0.88	0.88	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	17.11	11.52	3.84	3.14	3.14	0.00	0.35	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	3.43	0.76	1.14	0.00	0.00	0.00	0.00	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	6.67	0.74	2.22	0.00	1.11	0.37	0.00	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	22.09	9.18	10.71	0.68	1.02	0.17	0.34	0.00	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	15.41	7.40	4.32	0.46	0.15	0.92	0.15	0.15	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	40.29	5.89	8.06	0.77	0.46	0.00	0.46	0.46	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	123.77	13.71	12.31	4.82	2.16	0.38	1.78	1.14	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	68.45	3.40	15.88	1.89	0.38	0.00	0.00	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	52.02	1.42	6.65	1.20	0.33	0.00	0.44	0.76	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	90.22	8.79	10.10	7.17	3.26	0.98	1.95	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	34.36	43.70	6.76	11.49	3.22	11.60	0.64	1.07	1.50	1.18
testis, adult, pool2	10096-102C6	34.28	46.91	9.02	6.32	6.77	18.95	1.80	0.00	0.00	6.32
thalamus - adult, donor10196	10168-103B6	30.91	60.72	2.21	2.21	1.10	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	27.82	66.58	1.88	1.56	2.34	0.78	0.78	0.00	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	27.71	3.08	1.54	1.54	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.46	26.35	1.65	3.29	2.64	2.31	0.82	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	9.78	5.18	1.15	1.15	0.58	0.00	0.00	0.00	0.58	0.58
throat, adult	10209-103G2	32.21	29.21	5.24	3.00	2.75	2.50	0.50	0.50	0.00	0.50
throat, fetal, donor1	10061-101H7	14.02	8.84	5.18	0.61	0.30	0.61	0.00	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	29.41	0.00	23.85	0.40	0.40	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	33.50	22.27	13.42	3.58	1.99	1.89	0.10	0.00	0.00	0.89
thymus, fetal, pool1	10043-101F7	34.91	19.95	14.03	2.08	1.35	1.04	0.21	0.10	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	51.46	2.53	4.12	0.93	0.80	0.13	0.13	0.40	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	114.27	41.21	10.62	2.10	0.98	1.12	0.56	0.84	0.00	0.00
thyroid, adult, pool1	10028-101E1	13.06	2.71	3.55	1.49	0.56	0.09	0.00	0.00	0.00	0.09
thyroid, fetal, donor1	10060-101H6	33.75	11.07	7.12	0.79	1.05	0.26	0.26	0.00	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	30.80	9.24	3.08	0.00	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	22.33	22.79	4.19	3.49	2.56	1.16	0.23	0.23	0.00	0.47
tongue, fetal, donor1	10059-101H5	15.76	18.52	3.94	0.39	1.58	0.39	0.00	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	32.46	35.16	8.01	1.00	1.30	0.80	0.30	0.40	0.20	1.10
trachea, adult, pool1	10029-101E2	25.77	13.74	5.73	1.39	0.41	0.49	0.25	0.25	0.08	0.25
trachea, fetal, donor1	10058-101H4	38.85	14.23	2.31	1.54	1.15	0.00	0.38	0.00	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	1.42	3.90	0.00	0.35	0.00	0.35	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	77.10	4.56	8.00	1.93	0.61	0.30	0.41	0.30	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	74.90	7.99	12.22	2.98	2.19	0.31	1.57	0.00	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	47.56	5.71	17.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	36.06	9.06	8.04	0.93	0.08	0.25	0.08	0.00	0.00	0.25
umbilical cord, fetal, donor1	10057-101H3	14.61	16.69	8.35	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	13.99	4.78	9.38	1.02	0.34	0.34	0.17	0.17	0.00	0.00
uterus, fetal, donor1	10055-101H1	25.08	16.89	4.61	1.02	1.02	0.51	0.00	0.00	0.00	0.51
vagina, adult	10204-103F6	15.51	3.23	3.88	0.00	0.65	0.65	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	26.74	10.96	4.82	2.85	1.32	1.53	0.66	0.00	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.02	4.27	1.87	0.53	0.00	0.27	0.00	0.00	0.27	0.00